KOTANI Yasushi

Researcher Information

J-Global ID

• 201401033462104484

Research Interests

• 婦人科腫瘍   産婦人科   腹腔鏡下手術   

Research Areas

• Life sciences / Obstetrics and gynecology

Academic & Professional Experience

• 2020/04 - Today  近畿大学医学部 産科婦人科学教室 講師
• 2014/04 - 2020/03  Kindai UniversityFaculty of Medicine医学部講師
• 2009/04 - 2014/03  Kindai UniversityFaculty of Medicine助教A
• 2003/05 - 2005/03  Kindai UniversityFaculty of Medicine臨床研修医

Education

• 2005/04 - 2009/03  Kindai University  Faculty of Medicine  大学院医学研究科外科系専攻
• 1997/04 - 2003/03  Kindai University  Faculty of Medicine  Department of Medicine

Association Memberships

• 日本骨粗鬆症学会   日本婦人科ロボット手術学会   日本思春期学会   THE JAPAN SOCIETY FOR MEDICAL EDUCATION   日本女性骨盤底医学会   日本ロボット外科学会   日本女性医学会   JAPAN SOCIETY OF PERINATAL AND NEONATAL MEDICINE   日本婦人科腫瘍学会   日本内視鏡外科学会   JAPAN SOCIETY OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY AND MINIMALLY INVASIVE THERAPY   JAPAN SOCIETY OF OBSTETRICS AND GYNECOLOGY   

Published Papers

• 当院の再発子宮内膜癌に対するPembrolizumab+Lenvatinib治療

  佐藤 華子; 加嶋 洋子; 太田 真見子; 宮川 知保; 小谷 泰史; 中井 英勝; 松村 謙臣

  産婦人科の進歩 「産婦人科の進歩」編集室 75 (4) 558 - 558 0370-8446 2023/10
• 子宮肉腫133例から抽出された、画像的に悪性診断が困難である5例の病理組織学的検討

  大谷 知之; 山西 優紀夫; 小谷 泰史; 木戸 晶; 松村 謙臣

  日本病理学会会誌 (一社)日本病理学会 112 (2) 123 - 123 0300-9181 2023/10
• MRIを用いて子宮筋腫と子宮肉腫を術前に鑑別するアルゴリズムの検証

  山西 優紀夫; 小谷 泰史; 木戸 晶; 大谷 知之; 鈴木 彩子; 吉田 隆昭; 山ノ井 康二; 山口 建; 濱西 潤三; 万代 昌紀; 松村 謙臣

  日本婦人科腫瘍学会学術講演会プログラム・抄録集 (公社)日本婦人科腫瘍学会 65回 265 - 265 2023/07
• Diagnostic Utility of Hysteroscopic Biopsy in Cases of Suspected Lobular Endocervical Glandular Hyperplasia and Comparison with Cervical Conization

  Reona Shiro; Yasushi Kotani; Mamiko Ohta; Hanako Sato; Yoko Kashima; Kosuke Murakami; Kaoru Kawasaki; Hidekatsu Nakai; Noriomi Matsumura

  Healthcare MDPI AG 11 (11) 1619 - 1619 2023/06 [Refereed]
   

  Background: Cervical cystic lesions encompass a range of benign and malignant pathologies. Magnetic resonance imaging or cytology alone cannot provide a definitive diagnosis, and conventional practice involves performing a cervical biopsy by conization to confirm the histology in cases exhibiting potential signs of lobular endocervical glandular hyperplasia (LEGH) or malignancy. However, as postoperative complications resulting from conization can impact future fertility and pregnancy, alternative diagnostic methods are needed for reproductive-age patients. This study aimed to establish the efficacy of a hysteroscopic biopsy for diagnosing cervical cystic lesions and compare it with conization. Methods: Thirteen patients with cervical cystic lesions suspected of LEGH or malignancy underwent a hysteroscopic biopsy, while 23 underwent conization. Patient background information, preoperative evaluation, histology, and postoperative outcomes were collected and compared retrospectively. Results: No significant differences were found between the hysteroscopy and conization groups in terms of mean patient age (45 vs. 48 years), operating time (23 vs. 35 min), blood loss (small amount vs. 43 mL), and postoperative hospitalization (1.1 vs. 1.6 days). Conclusion: A hysteroscopic biopsy allows for targeted resection of the cervix while maintaining diagnostic accuracy. It may serve as an efficient method for diagnosing cervical cystic lesions.
• Development of an Algorithm to Differentiate Uterine Sarcoma from Fibroids Using MRI and LDH Levels.

  Ayako Suzuki; Aki Kido; Mitsuru Matsuki; Yasushi Kotani; Kosuke Murakami; Yukio Yamanishi; Isao Numoto; Hidekatsu Nakai; Tomoyuki Otani; Ikuo Konishi; Masaki Mandai; Noriomi Matsumura

  Diagnostics (Basel, Switzerland) 13 (8) 2023/04 [Refereed]
   

  BACKGROUND: This study aimed to establish an evaluation method for detecting uterine sarcoma with 100% sensitivity using MRI and serum LDH levels. METHODS: One evaluator reviewed the MRI images and LDH values of a total of 1801 cases, including 36 cases of uterine sarcoma and 1765 cases of uterine fibroids. The reproducibility of the algorithm was also examined by four evaluators with different imaging experience and abilities, using a test set of 61 cases, including 14 cases of uterine sarcoma. RESULTS: From the MRI images and LDH values of 1801 cases of uterine sarcoma and uterine fibroids, we found that all sarcomas were included in the group with a high T2WI and either a high T1WI, an unclear margin, or high LDH values. In addition, when cases with DWI were examined, all sarcomas had high DWI. Among the 36 sarcoma cases, the group with positive findings for T2WI, T1WI, margins, and serum LDH levels all had a poor prognosis (p = 0.015). The reproducibility of the algorithm was examined by four evaluators and the sensitivity of sarcoma detection ranged from 71% to 93%. CONCLUSION: We established an algorithm to distinguish uterine sarcoma if tumors in the myometrium with low T2WI and DWI are present.
• Treatment for Locally Resectable Stage IIIC1 Cervical Cancer: A Retrospective, Single-Institution Study.

  Yoko Kashima; Kosuke Murakami; Chiho Miyagawa; Hisamitsu Takaya; Yasushi Kotani; Hidekatsu Nakai; Noriomi Matsumura

  Healthcare (Basel, Switzerland) 11 (5) 2023/02 [Refereed]
   

  According to the revision of the FIGO 2018 staging system, cervical cancer with pelvic lymph node metastases was changed to stage IIIC1. We retrospectively analyzed the prognosis and complications of locally resectable (classified as T1/T2 by TNM classification of the Union for International Cancer Control) stage IIIC1 cervical cancer. A total of 43 patients were divided into three groups: surgery with chemotherapy (CT) (ope+CT group) (T1; n = 7, T2; n = 16), surgery followed by concurrent chemoradiotherapy (CCRT), or radiotherapy (RT) (ope+RT group) (T1; n = 5, T2; n = 9), and CCRT or RT alone (RT group) (T1; n = 0, T2; n = 6). In T1 patients, recurrence was observed in three patients, but there was no difference among the treatment groups, and no patients died. In contrast, in T2 patients, recurrence and death were observed in nine patients (8 in ope+CT; 1 in ope+RT), and recurrence-free survival and overall survival were lower in the ope+CT group (p = 0.02 and 0.04, respectively). Lymphedema and dysuria were more common in the ope+RT group. A randomized controlled trial comparing CT and CCRT as an adjuvant therapy after surgery in T1/T2 patients, including those with pelvic lymph node metastases, is currently underway. However, our data suggest that performing CT alone after surgery in T2N1 patients is likely to worsen the prognosis.
• Recurrence of low-grade serous ovarian cancer successfully treated with Gemcitabine and Bevacizumab: a case report and literature review

  Hanako Sato; Yasushi Kotani; Chiho Miyagaw; Tamaki Yahata; Kosuke Murakami; Hidekatsu Nakai; Tomoyuki Otani; Noriomi Matsumura

  European Journal of Gynaecological Oncology 43 107 - 111 2022/10 [Refereed]
  
• Risk factors for future osteoporosis in perimenopausal Japanese women.

  Akiko Kanto; Yasushi Kotani; Kosuke Murakami; Junko Tamaki; Yuho Sato; Sadanobu Kagamimori; Noriomi Matsumura; Masayuki Iki

  Menopause (New York, N.Y.) 2022/08 [Refereed]
   

  OBJECTIVE: The aims of this study were to investigate trends in bone mineral density (BMD) loss and related factors in early postmenopausal women in Japan, identify risk factors for future osteoporosis, and predict osteoporosis before it occurs. METHODS: The study population consisted of women who were 50 to 54 years old at the time of the survey in 2002 or 2006. The study included a questionnaire and physical measurement findings (BMD, height, body weight [WT], body mass index [BMI], and handgrip strength). One hundred sixty-seven women continued to participate in the study and had BMD measurements at the 9- or 10-year follow-up of the Japanese Population-based Osteoporosis study. Statistical analyses were performed using Pearson correlation to examine each factor of physical measurement and BMD for lumbar spine (LS) and femoral neck (FN). The receiver operating characteristic curve of this data was also predictive of osteoporosis in 2011 for 2002 data; BMD at the age of 50 to 54 years was then used to predict the likelihood of being diagnosed with osteoporosis 9 and 10 years later. RESULTS: At the baseline in 2002 and 2006, WT, BMI, height, and handgrip strength were positively correlated with BMD. The optimal cutoff values for BMD in 2006 to predict osteoporosis in 2016 were LS less than 0.834 g/cm2 and FN less than 0.702 g/cm2. These data were also predictive of osteoporosis in 2011 for 2002 data; applying this to the 2002 data, LS/FN had a sensitivity of 92%/100%, a specificity of 87%/81%, a positive predictive value of 55%/48%, and a negative predictive value of 98%/100%. The larger WT and BMI also resulted in a greater decrease in BMD of FN after 9 or 10 years. CONCLUSIONS: We have identified a cutoff value for BMD to predict future osteoporosis in menopausal women and found a negative correlation between WT and BMI in menopausal women and changes in BMD of the FN over the next 10 years.
• Surgical skill and oncological outcome of laparoscopic radical hysterectomy: JGOG1081s-A1, an ancillary analysis of the Japanese Gynecologic Oncology Group Study JGOG1081

  Eiji Kobayashi; Eiji Nakatani; Tomohito Tanaka; Kawai Yosuke; Hiroyuki Kanao; Yasuhiko Shiki; Yasushi Kotani; Tsutomu Hoshiba; Rie Minami; Hiroshi Yoshida; Satoru Kyo; Masae Yorimitsu; Tsuyoshi Yamashita; Tetsuya Hasegawa; Toshiaki Matsuura; Seiji Kagami; Toru Fujioka; Tanaka Hirohiko; Shin Nishio; Munetaka Takekuma; Mikio Mikami; Takayuki Enomoto

  Gynecologic Oncology Elsevier BV 165 (2) 293 - 301 0090-8258 2022/05 [Refereed]
   

  Objectives: We investigated whether surgical skill and procedure were related to oncological outcomes in cervical cancer patients who underwent Laparoscopic Radical Hysterectomy (LRH). Methods: We previously assessed data of LRH from 251 patients with FIGO stage (2009) IA2, IB1and IIA1 cervical cancer collected for JGOG 1081s study. 1) The JGOG 1081s cohort study was re-examined to refine the surgical details and extend the follow-up period as chart review. 2) Unedited videos for recurrent cases and matched non-recurrent control cases were newly compared by experts for various surgical skills and surgical procedures using the modified Objective Structured Assessment of Technical Skills (OSATS) tool, without awareness of the recurrence status as video review. Results: After a median follow-up of 46 months, tumors had recurred in 31 of the 251 patients. The five-year Recurrence-Free Survival rate was 86.9% (81.8–90.6) and five-year Overall Survival rate was 93.7% (87.5–96.8). Multivariate analysis from chart reviews found that an experience with LRH of less than 20 cases per institution was an independent prognostic factor for recurrence (Hazard Ratio (HR) 2.49, 95%CI 1.12–5.53, p = 0.025). For the surgical video review, we compared 23 videos of recurrent cases with 23 background-matched non-recurrent controls. Lower modified OSATS scores from the video review were consistently trended to have a higher risk of recurrence. Conclusions: Our new study has found that LRH surgical experience and skill trended to have better oncological outcomes.
• Comparison of surgical results and postoperative recurrence rates by laparoscopic sacrocolpopexy with other surgical procedures for managing pelvic organ prolapse

  Yasushi Kotani; Kosuke Murakami; Sayaka Kai; Tamaki Yahata; Akiko Kanto; Noriomi Matsumura

  Gynecology and Minimally Invasive Therapy Medknow 10 (4) 221 - 225 2213-3070 2021/10 [Refereed]
  
• Clinical efficacy and safety of laparoscopic paraaortic lymph node dissection for locally advanced cervical cancer

  宮川知保; 村上幸祐; 太田真見子; 佐藤華子; 山本貴子; 城玲央奈; 小谷泰史; 松村謙臣

  産婦人科の進歩 73 (3) 191 - 196 0370-8446 2021/08 [Refereed]
  
• Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma

  Kosuke Murakami; Akiko Kanto; Kazuko Sakai; Chiho Miyagawa; Hisamitsu Takaya; Hidekatsu Nakai; Yasushi Kotani; Kazuto Nishio; Noriomi Matsumura

  Modern Pathology Springer Science and Business Media LLC 34 (11) 2071 - 2079 0893-3952 2021/06 [Refereed]
   

  Recent studies have reported cancer-associated mutations in normal endometrium. Mutations in eutopic endometrium may lead to endometriosis and endometriosis-associated ovarian cancer. We investigated PIK3CA mutations (PIK3CAm) for three hotspots (E542K, E545K, H1047R) in eutopic endometrium in patients with ovarian cancer and endometriosis from formalin-fixed paraffin-embedded specimens by laser-capture microdissection and droplet digital PCR. The presence of PIK3CAm in eutopic endometrial glands with mutant allele frequency ≥ 15% were as follows: ovarian clear cell carcinoma (OCCC) with PIK3CAm in tumors, 20/300 hotspots in 11/14 cases; OCCC without PIK3CAm, 42/78 hotspots in 11/12 cases; high-grade serous ovarian carcinoma, 8/45 hotspots in 3/5 cases; and endometriotic cysts, 5/63 hotspots in 5/6 cases. These rates were more frequent than in noncancer nonendometriosis controls (7/309 hotspots in 5/17 cases). In OCCC without PIK3CAm, 7/12 (58%) cases showed multiple hotspot mutations in the same eutopic endometrial glands. In 3/54 (5.6%) cases, PIK3CAm was found in eutopic endometrial stroma. Multisampling of the OCCC tumors with PIK3CAm showed intratumor heterogeneity in three of eight cases. In two cases, PIK3CAm was detected in the stromal component of the tumor. Homogenous PIK3CAm in the epithelial component of the tumor matched the mutation in eutopic endometrial glands in only one case. Eutopic endometrial glands in ovarian cancer and endometriosis show high frequency of PIK3CAm that is not consistent with tumors, and multiple hotspot mutations are often found in the same glands. While the mutations identified in eutopic endometrium may not be driver mutations in the patient’s cancer, these are still driver mutations but this specific clone has not undergone the requisite steps for the development of cancer.
• Lower leg compartment syndrome following laparoscopic uterine malignancy surgery for uterine cancer complicated by rheumatoid arthritis: a case report and literature review

  Hanako Sato; Yasushi Kotani; Shiro Takamatsu; Mamiko Ohta; Reona Shiro; Kiko Yamamoto; Kosuke Murakami; Noriomi Matsumura

  European Journal of Gynaecological Oncology IMR Press 42 (3) 590 - 594 0392-2936 2021/06 [Refereed]
  
• Quality of life after laparoscopic hysterectomy versus abdominal hysterectomy

  Yasushi Kotani; Kosuke Murakami; Risa Fujishima; Akiko Kanto; Hisamitsu Takaya; Masao Shimaoka; Hidekatsu Nakai; Noriomi Matsumura

  BMC Women's Health Springer Science and Business Media LLC 21 (219) 2021/05 [Refereed]
   

  Laparoscopic surgery has been described as a minimally invasive surgery. The purpose of this study is to clarify its minimal invasive features using a patient questionnaire on the postoperative quality of life (QOL) over various time periods following either laparoscopic hysterectomy (LH) or abdominal hysterectomy (AH) and to compare the results. This study enrolled 28 patients who underwent total hysterectomy for uterine fibroids in 2012 (14 AH cases and 24 LH cases) were enrolled in this study. The 36-Item Short Form Survey (SF-36) questionnaire was completed on postsurgical day 3; weeks 1, 2, and 4; and month 6. The results were compared between the two groups. Patients who underwent LH scored significantly higher on physical functioning on postoperative day 3 and week 2; physical role and bodily pain on day 3 and week 1; general health on postoperative day 3, weeks 1, 2, and 4, and month 6; social functioning on day 3; and emotional role on day 3 and week 1. No significant differences were found between vitality and mental health at any time point or in the categories above at any other time point. Postoperative QOL in LH cases was improved on day 3 and week 1; however, no significant differences between the LH and AH groups were found in most categories at week 4 and month 6. LH leads to superior short-term QOL early in the postoperative period relative to AH.
• Ovarian cyst elevation using a metreurynter for laparoscopic cystectomy of a benign ovarian cyst during pregnancy.

  Yasushi Kotani; Kosuke Murakami; Kiko Yamamoto; Risa Fujishima; Tamaki Yahata; Yoshie Yo; Masao Shimaoka; Noriomi Matsumura

  BMC pregnancy and childbirth 21 (1) 321 - 321 2021/04 [Refereed]
   

  BACKGROUND: A uterine manipulator cannot be used to elevate the ovary in benign ovarian surgery during pregnancy. This report describes our method of elevation of the ovary using a metreurynter with the success rate of the procedure and a comparison of surgical results and pregnancy outcomes between the successful and unsuccessful cases. METHODS: Between August 2003 and February 2020, 11 pregnant patients with a tumor found sunk in the Cul-de-sac underwent laparoscopic cystectomy for a benign ovarian cyst with a metreurynter. The surgical results, success and failure of the elevation by a metreurynter, pregnancy outcomes, and fetal status at delivery were evaluated. RESULTS: Elevation of ovarian tumors with a metreurynter was successful in nine cases. However, it was unsuccessful in the remaining two cases wherein the ovary was lifted with forceps while the uterus was in a compressed state. The operative time was also longer in these cases. The pregnancy prognosis, however, was good for both, successful and unsuccessful cases. CONCLUSIONS: The metreurynter is an inexpensive and practical obstetric device, and its optimal use allows the performance of a procedure with minimal burden on a pregnant uterus. Therefore, we recommend the appropriate use of this method to enable effective laparoscopic cystectomy of ovarian tumors during pregnancy.
• Measures for safe laparoscopic sacrocolpopexy: Preoperative contrast-enhanced computed tomography and perioperative ultrasonography

  Yasushi Kotani; Kosuke Murakami; Akiko Kanto; Hisamitsu Takaya; Hidekatsu Nakai; Noriomi Matsumura

  Gynecology and Minimally Invasive Therapy Medknow 10 (2) 114 - 116 2213-3070 2021/04 [Refereed]
  
• A case report of bladder and intestinal endometriosis, and the relationship between sex hormone receptor expression and PIK3CA mutation analysis.

  Akiko Kanto; Yasushi Kotani; Kosuke Murakami; Chiho Miyagawa; Hidekatsu Nakai; Noriomi Matsumura

  BMC women's health 21 (1) 118 - 118 2021/03 [Refereed]
   

  BACKGROUND: Extragonadal endometriosis is a rare condition, and its disease manifestation and long-term prognosis have not been elucidated. We report an extragonadal endometriosis case controlled by drug therapy for 14 years with analysis of the sex hormone receptor expression and PIK3CA mutation. CASE PRESENTATION: The patient was diagnosed with bladder endometriosis at age of 30 years, and underwent bilateral nephrostomy and GnRHa therapy with add-back therapy. The patient was switched to dienogest therapy at age 35 and had hematuria and bloody stools at age 38. PET-CT revealed a 6-cm mass in the bladder with fluorodeoxyglucose accumulation and the diagnosis of endometriosis in the bladder, sigmoid colon, and cecum was confirmed after the biopsy result. The lesion's tubular structures were positive for the estrogen receptor, but only 30% positive for the progesterone receptor, and the H1047R mutation in PIK3CA was found in tubular structures of the bladder lesion. GnRHa therapy caused the tumors to shrink. CONCLUSION: Decreased progesterone receptor expression and oncogenic mutations may influence the course of less common and rare site endometriosis. Rare site endometriosis often requires long-term hormone therapy, and management should be tailored to the patient's life stage, keeping in mind complications, such as decreased bone density.
• Relationship between cervical elastography and spontaneous onset of labor

  Yoshie Yo; Yasushi Kotani; Reona Shiro; Kiko Yamamoto; Risa Fujishima; Hisamitsu Takaya; Ayako Suzuki; Masao Shimaoka; Noriomi Matsumura

  Scientific Reports Springer Science and Business Media LLC 10 (1) 2020/12 [Refereed]
   

  Cervical elastography might be an objective method for evaluating cervical ripening during pregnancy, but its usefulness has not been fully investigated. We examined the significance of cervical elastography in the last trimester of pregnancy. Cervical elastography was performed at weekly checkups after 36 weeks of gestation in 238 cases delivered at our hospital from 2017 to 2018. The correlation with the onset time of natural labor, which is an index for judging maternal delivery preparation status, was examined. A total of 765 examinations were conducted, and cervical stiffness determined by cervical elastography was positively correlated with the Bishop score (r = 0.46, p < 0.0001). When examined separately for each week, only the examinations performed at 39 weeks were associated with the onset of spontaneous labor up to 7 days later (p = 0.0004). Furthermore, when stratified and analyzed by the Bishop score at 39 weeks of gestation, cervical elastography was associated with the occurrence of spontaneous labor pain for up to seven days in the groups with Bishop scores of 3–5 and 6–8 (p = 0.0007 and p = 0.03, respectively). In conclusion, cervical elastography at 39 weeks of pregnancy is useful for judging the delivery time.
• Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy.

  Kosuke Murakami; Yasushi Kotani; Hidekatsu Nakai; Noriomi Matsumura

  Cancers 12 (6) 2020/06 [Refereed]
   

  Endometrial cysts (ECs) are thought to be the origin of endometriosis-associated ovarian cancer (EAOC). A hypothesis that the oxidative stress of iron in cysts causes "malignant transformation of ECs" has been proposed, but this has not been verified. Several population-based studies showed that endometriosis was a risk factor but did not reflect the "malignant transformation of ECs". A review showed that most patients were diagnosed with EAOC early in monitoring following detection of ECs, and that these cases might have been cancer from the start. Epidemiologically, EAOC was reduced by hysterectomy rather than by cystectomy of ECs. Gene mutation analyses identified oncogenic mutations in endometriosis and normal endometrium and revealed that the same mutations were present at different endometriotic lesions. It was also shown that most of the gene mutations found in endometriosis occurred in normal endometrium. Taking together, EAOC might be caused by eutopic endometrial glandular epithelial cells with oncogenic mutations that have undergone menstrual blood reflux and engrafted in the ovary, rather than by low-risk ECs acquiring oncogenic mutations and becoming malignant. This review discusses the mechanisms of EAOC development and targeted therapy based on genetic variation in EAOC with a focus on eutopic endometrium.
• A case of left renal atrophy following the development of an infected giant retroperitoneal chylous cyst after laparoscopic para-aortic lymphadenectomy for endometrial cancer

  Takuma Ohsuga; Yasushi Kotani; Shiro Takamatsu; Kosuke Murakami; Hidekatsu Nakai; Noriomi Matsumura

  International Cancer Conference Journal 9 203 - 206 2020/06 [Refereed]
  
• Superparamagnetic iron oxide as a tracer for sentinel lymph node detection in uterine cancer: a pilot study.

  Kosuke Murakami; Yasushi Kotani; Ayako Suzuki; Hisamitsu Takaya; Hidekatsu Nakai; Mitsuru Matsuki; Takao Sato; Masaki Mandai; Noriomi Matsumura

  Scientific reports 10 (1) 7945 - 7945 2020/05 [Refereed]
   

  Sentinel lymph node (SLN) mapping using dye or radioisotopes has been performed in patients with uterine cancer. Superparamagnetic iron oxide (SPIO) can be handled safely and is taken up by lymph nodes (LNs); however, its efficacy in detecting SLNs in uterine cancer remains unknown. This pilot study evaluated the use of SPIO as a tracer for SLN detection in patients with uterine cancer. SPIO was injected into the uterine cervixes of 15 patients with uterine cancer scheduled for pelvic LN dissection. Magnetic resonance imaging (MRI) was performed preoperatively. Five patients also underwent radioisotope injection and single-photon emission computed tomography/computed tomography. Dissected LNs were stained with iron and examined pathologically. Of the radioisotope-positive LNs, 92% were also SPIO/MRI-positive. SPIO/MRI and iron staining were positively correlated. SLNs were identified by iron staining in 93% of cases. Iron staining was strongly positive in two of the five areas of LN metastasis; these were considered SLNs. Staining was negative or very weak in the other three areas and lymph flow disturbance was considered. SPIO and radioisotopes are taken up similarly by SLNs. SPIO/MRI and iron staining may thus be useful for detection of SLNs and diagnosis of LN metastasis in patients with uterine cancer.
• Effectiveness of laparoscopic ultrasonography in laparoscopic myomectomy.

  Mamoru Shigeta; Yasushi Kotani; Risa Fujishima; Yoshie Yo; Kosuke Murakami; Hisamitsu Takaya; Hidekatsu Nakai; Ayako Suzuki; Isao Tsuji; Noriomi Matsumura

  Asian journal of endoscopic surgery 13 (2) 200 - 204 1758-5902 2020/04 [Refereed]
   

  INTRODUCTION: Laparoscopic myomectomy (LM) has become increasingly common in recent years because it minimizes invasiveness. However, myoma can recur after myomectomy. Therefore, we began using laparoscopic ultrasonography, which involves inserting a probe into the peritoneal cavity via a trocar and placing it in direct contact with the uterus. During surgery, this enables the detection of myomas as a small as 1 mm in diameter, which are often undetectable on MRI. Here, we report the effectiveness of laparoscopic ultrasonography. METHODS: The subjects were 26 women who underwent LM at our institution from February 2015 to December 2016. Preoperative MRI was performed, and all myomas detected on MRI were removed during LM. Laparoscopic ultrasonography was then performed to assess for residual myomas, which were removed. RESULTS: In six patients (23%), residual myomas were identified on laparoscopic ultrasonography after the first enucleation of the myomas detected on preoperative MRI. All detected residual myomas, the largest of which was less than 10 mm in diameter, were removed. CONCLUSION: Small myomas undetectable on preoperative MRI were detected on laparoscopic ultrasonography and removed.
• Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts.

  Kosuke Murakami; Yasushi Kotani; Reona Shiro; Hisamitsu Takaya; Hidekatsu Nakai; Noriomi Matsumura

  International journal of clinical oncology 25 (1) 51 - 58 1341-9625 2020/01 [Refereed]
   

  BACKGROUND: Endometriosis is a risk factor for ovarian cancer. Endometriosis-associated ovarian cancer (EAOC), most commonly clear cell carcinoma, is believed to develop from ovarian endometrial cysts. In this study, we reviewed published cases of EAOC considered to have developed from endometrial cysts, and focused on the observation period. METHODS: We searched for articles published since January 2000 that reported cases of ovarian cancer thought to have originated from endometrial cysts using PubMed, Web of Science, and Ichushi-Web. The period from the start of follow-up of the endometrial cyst to the diagnosis of ovarian cancer was calculated. RESULTS: Seventy-nine cases were identified from 32 articles. The median period from the diagnosis of endometrial cysts to the diagnosis of ovarian cancer was only 36 months. Approximately 75% of cases developed into cancer within 60 months and most cases developed within 120 months. CONCLUSION: Our results suggest that clinically detectable cysts subsequently diagnosed as ovarian cancer might already have contained cancer cells. Therefore, the mechanism of EAOC development needs to be re-examined and appropriate management guidelines need to be developed.
• Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma using Magnetic Resonance Images: A Literature Review.

  Suzuki A; Aoki M; Miyagawa C; Murakami K; Takaya H; Kotani Y; Nakai H; Matsumura N

  Healthcare (Basel, Switzerland) MDPI AG 7 (4) 158 - 158 2019/12 [Refereed]
   

  MRI plays an essential role in patients before treatment for uterine mesenchymal malignancies. Although MRI includes methods such as diffusion-weighted imaging and dynamic contrast-enhanced MRI, the differentiation between uterine myoma and sarcoma always becomes problematic. The present paper discusses important findings to ensure that sarcomas are not overlooked in magnetic resonance (MR) images, and we describe the update in the differentiation between uterine leiomyoma and sarcoma with recent reports.
• Clinical Determinants Affecting Indications for Surgery and Chemotherapy in Recurrent Ovarian Granulosa Cell Tumor.

  Nakai H; Koike E; Murakami K; Takaya H; Kotani Y; Nakai R; Suzuki A; Aoki M; Matsumura N; Mandai M

  Healthcare (Basel, Switzerland) 7 (4) 2019/11 [Refereed]
  
• Conservative treatment of retained placenta in six patients: Analysis of conservative medical treatment against retained placenta was possible in six cases

  Risa Fujishima; Masao Shimaoka; Kiko Yamamoto; Chiho Miyagawa; Yoshie Yo; Akiko Kanto; Yasushi Kotani; Ayako Suzuki; Noriomi Matsumura

  Acta Medica Kinki University 44 13 - 19 2019/07 [Refereed]
  
• Association between preterm delivery and bacterial vaginosis with or without treatment.

  Shimaoka M; Yo Y; Doh K; Kotani Y; Suzuki A; Tsuji I; Mandai M; Matsumura N

  Scientific reports 9 (1) 509  2019/01 [Refereed]
  
• 鼠径ヘルニアを伴った小児の正常卵巣茎捻転に対して、腹腔鏡下で鼠径ヘルニア修復と卵巣固定術を行った1例

  青木 稚人; 小谷 泰史; 高矢 寿光; 中井 英勝; 辻 勲; 松村 謙臣

  産婦人科の進歩 70 (3) 305 - 310 2018/08 [Refereed]
  
• Recurrence of uterine myoma after myomectomy: Open myomectomy versus laparoscopic myomectomy

  Yasushi Kotani; Takako Tobiume; Risa Fujishima; Mamoru Shigeta; Hisamitsu Takaya; Hidekatsu Nakai; Ayako Suzuki; Isao Tsuji; Masaki Mandai; Noriomi Matsumura

  Journal of Obstetrics and Gynaecology Research Blackwell Publishing 44 (2) 298 - 302 1447-0756 2018/02 [Refereed]
   

  Aim: Open myomectomy (OM) was previously frequently performed however, laparoscopic myomectomy (LM) has recently become more common. Nevertheless, myoma can recur after both LM and OM. In this study, we report our retrospective investigation of myoma recurrence by comparing LM and OM. Methods: A total of 474 patients underwent LM and 279 patients underwent OM. The patients were followed-up postoperatively from six months to eight years. Recurrence was confirmed when a myoma with a diameter of ≥ 1 cm was detected. Post-LM, post-OM and cumulative recurrence rates were investigated, and a Cox hazard test was performed. Results: The cumulative recurrence rates between the two groups were 76.2% (LM) vs. 63.4% (OM) at eight years postoperatively. A log-rank test revealed a significant difference between the two groups. Cox hazard testing revealed that LM, a larger number of enucleated myoma masses and the absence of postoperative gestation significantly contributed to the postoperative recurrence rate. Conclusions: LM yielded a higher recurrence rate than OM, likely a result of manual myoma removal in OM, which is a more exhaustive extraction of smaller myoma masses than performed in LM. In other words, fewer residual myoma masses after OM contribute to a lower postoperative recurrence rate.
• 当科における広汎子宮全摘術(ロボット支援下手術、腹腔鏡手術、開腹手術)の各アプローチ法による比較検討

  中井 英勝; 小谷 泰史; 山本 貴子; 藤島 理沙; 宮川 知保; 青木 稚人; 重田 護; 葉 宜慧; 高松 士朗; 村上 幸祐; 貫戸 明子; 高矢 寿光; 島岡 昌生; 飛梅 孝子; 辻 勲; 鈴木 彩子; 万代 昌紀

  近畿大学医学雑誌 近畿大学医学会 42 (3-4) 99 - 103 0385-8367 2017/12 [Refereed]
   

  目的 内視鏡下広汎子宮全摘術には腹腔鏡下広汎子宮全摘術とロボット支援下広汎子宮全摘術が含まれ、現在先進医療として限定された施設で導入され始めている。当科ではこの2つの内視鏡下術式について倫理委員会の承認のもと先進医療導入前から施行してきた数少ない施設である。今回われわれは内視鏡下広汎子宮全摘術を、同時期に行った開腹術と比較検討し、当科で経験した合併症や治療特性から導入と先進医療の普及にあたっての注意点について検討を行った。対象と方法 ロボット支援下広汎子宮全摘術(以下ロボット)は7例施行し、腹腔鏡下広汎子宮全摘術(以下腹腔鏡)は9例施行した。また同時期に行った開腹術32例を比較検討した。検討項目は年齢、BMI、手術時間、出血量、摘出リンパ節個数、術後在院日数の平均値の比較と輸血率、周術期合併症について比較検討した。また、ロボット支援下広汎子宮全摘術の詳細についても同時に検討した。結果 ロボット、腹腔鏡、開腹術での比較で、平均手術時間でロボットは他の2群より有意に長時間手術であった。また平均出血量では開腹術が他の2群より有意に多かった。また平均摘出リンパ節個数は、開腹群で他の2郡と比較して有意に多く摘出された。また平均術後在院日数は開腹術が他の2群より有意に長期の入院を必要とした。年齢、BMI、輸血率、周術期合併症に差は認めなかった。また、ロボット支援下広汎子宮全摘術の周術期合併症は2例であり、ともに尿路合併症であった。結論 内視鏡下手術は開腹術と比較し低侵襲であったが、摘出リンパ節個数が少なく、手術時間が長く、今後の課題と考えられた。また、ロボット支援下広汎子宮全摘術では過度の広汎性を追求しすぎた結果起こったと考えられる尿路系合併症を2例経験し、導入初期では注意が必要と考えられた。(著者抄録)
• 腹腔鏡トレーニングボックスを用いた医学教育実習の導入と経験

  鈴木 彩子; 小谷 泰史; 山本 貴子; 藤島 理沙; 宮川 知保; 青木 稚人; 重田 護; 葉 宜慧; 高松 士朗; 村上 幸祐; 貫戸 明子; 高矢 寿光; 島岡 昌生; 飛梅 孝子; 中井 英勝; 辻 勲; 万代 昌紀

  近畿大学医学雑誌 近畿大学医学会 42 (3-4) 105 - 108 0385-8367 2017/12 [Refereed]
   

  緒言 近年内視鏡手術は患者のQOL向上の観点から、スタンダードになりつつある。一方、近年産婦人科入局者は減少傾向にある。そこで学生時代から産婦人科や内視鏡手術に興味を持ってもらうために、医学生に腹腔鏡トレーニングボックスを用いた医学教育実習を導入した。今回われわれは、本実習の導入における経験とその有用性を報告する。方法と対象 産婦人科実習を行った医学部生97名を対象とし、2台のボックスを用いて実習を行った。実習内容は、(1)5個のおはじきを移す手技(以下「おはじきうつし」)、(2)ハサミで紙を切る、(3)縫合、(4)「おはじきうつし」を再度行う、とした。「おはじきうつし」はタイムを測定し、(1)と(4)のタイムを比較検討した。また2週間の実習終了後に、全員にアンケート調査を行い、満足度を検討した。結果「おはじきうつし」の前後での平均タイムは前199±96秒と156±97秒と、実習施行後で有意に短くなった。また、2週間実習終了後のアンケートでは、ほぼ全員満足であるという結果が得られた。考察 腹腔鏡手術は満足度が高く、腹腔鏡トレーニングボックスを用いた実習は、医学生にとって、産婦人科ないしは内視鏡手術への興味を持ってもらう一助になると考えられた。(著者抄録)
• Ultrasonic scalpel ablation for vaginal intraepithelial neoplasia occurring after hysterectomy

  K. Murakami; H. Nakai; M. Aoki; H. Takaya; M. Ukita; Y. Kotani; M. Shimaoka; T. Tobiume; I. Tsuji; A. Suzuki; M. Mandai

  EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY I R O G CANADA, INC 38 (4) 541 - 546 0392-2936 2017 [Refereed]
   

  Purpose of investigation: This pilot study aimed to assess the feasibility and efficacy of ultrasonic scalpel ablation for vaginal intraepithelial neoplasia (VAIN) Grade 3 lesions occurring after hysterectomy for cervical malignancies. Materials and Methods: A total of 11 cases of VAIN 3 that occurred after hysterectomy for cervical in-situ and invasive carcinoma were treated using ultrasonic scalpel ablation. The clinical courses and treatment outcomes of the cases were retrospectively analyzed along with four cases that were treated using conventional CO2 laser vaporization. A review of related articles was conducted to compare the therapeutic efficacy and indications for various treatments. Results: In all of the cases, the procedure was conducted safely with no significant complications. After treatment, the cytology of the vaginal stump was normalized in 14 cases (93.3%). One patient's cytology was not normalized; she was treated with a partial vaginectomy. Re-recurrence occurred in three of the four (75%) patients treated with CO2 laser vaporization and three of the 11 (27.3%) patients treated with ultrasonic ablation. All but one patient remained free of disease after the second treatment for VAIN. Conclusion: Ultrasonic ablation may be feasible and convenient and as effective as CO2 laser vaporization for the treatment of VAIN after hysterectomy.
• Determinant factors of postoperative recurrence of endometriosis: difference between endometrioma and pain

  T. Tobiume; Y. Kotani; H. Takaya; H. Nakai; I. Tsuji; A. Suzuki; M. Mandai

  EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY ELSEVIER SCIENCE BV 205 54 - 59 0301-2115 2016/10 [Refereed]
   

  Objective: Although the postoperative use of hormonal treatment for endometriosis is recommended in the European Society of Human Reproduction and Embryology guidelines to prevent the recurrence of endometriosis-associated dysmenorrhoea, hormonal treatment may not be necessary for all patients who undergo surgical treatment for endometriosis. The aim of this study was to clarify the determinant factors that predict the recurrence of endometriosis after surgery in order to develop personalized hormonal treatment recommendations. Factors associated with the recurrence of endometrioma and pain were investigated independently to identify the likelihood of recurrence in each individual patient. Study design: Between 2008 and 2013, 352 patients underwent surgery and were diagnosed with endometriosis based on pathological findings at the study hospital. Among these patients, 191 experienced a recurrence of endometrioma in the absence of pre- or postoperative hormonal treatment. Various clinical factors such as pre-operative pain, intra-operative findings and postoperative improvement of pain were compared between patients who experienced recurrence after surgery and those who did not. Results: The cumulative 5-year recurrence rate of endometrioma was 28.7% among the 191 patients who did not undergo pre- or postoperative hormonal treatment. Significant differences were detected in maximum tumour diameter, revised American Society for Reproductive Medicine score (r-ASRM score), operative time and operative blood loss between patients in the recurrent endometrioma group and the non-recurrent endometrioma group; only the r-ASRM score was significantly correlated with recurrence of endometrioma in the multivariate analysis. The cumulative 5-year rate of persistent/recurrent pain was 33.4%. There were significant differences in the postoperative improvement of pain between the persistent/recurrent pain group and the non-recurrent pain group according to the univariate and multivariate analyses. Conclusion: This study suggests that the risk factors for recurrence of endometrioma differ from the risk factors for recurrence of pain. The use of postoperative hormonal treatment should be considered based on the dominant risk factors and needs of each patient. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
• Nontuberculous Mycobacterial Infection in the Uterine Cervix Mimics Invasive Cervical Cancer in Immunocompetent Woman

  Masayo Ukita; Masato Aoki; Kosuke Murakami; Hisamitsu Takaya; Yasushi Kotani; Masao Shimaoka; Takako Tobiume; Hidekatsu Nakai; Isao Tsuji; Ayako Suzuki; Masaki Mandai

  INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY LIPPINCOTT WILLIAMS & WILKINS 35 (2) 127 - 133 0277-1691 2016/03 [Refereed]
   

  Nontuberculous mycobacterial (NTM) infection is increasing across the world. Although the most common clinical manifestation of NTM disease is lung disease, a rare form of disseminated NTM disease has also been documented. Disseminated NTM usually develops in severely immunocompromised individuals, especially those with advanced AIDS. This manifestation is rare in non-HIV-infected hosts and is associated with immunosuppressed conditions. However, recent reports have suggested that disseminated NTM disease in immunocompetent patients without HIV infection has been increasing. Dissemination may involve any organ system, but a case in the female genital tract has never been reported. We report a case in a 67-yr-old previously healthy woman who presented with a disseminated NTM infection in the uterine cervix. The primary presentation was general fatigue and body weight loss. The patient also presented with a mass formation that mimicked cervical cancer on magnetic resonance imaging. In addition to the cervical mass, the patient presented with a mass formation in the omentum; wall thickening of the vagina, bladder, and ureter; and retention of pleural/peritoneal fluid. Vaginal cytology was negative. A diagnosis was made only after detecting acid-fast bacilli in a biopsy specimen of cervical mass, which was conducted under suspicion of cervical malignancy. Then, Mycobacterium aviumwas confirmed in a polymerase chain reaction test of cervical tissue. After administration of antimycobacterial therapy, the mass and other findings on magnetic resonance imaging disappeared. Infection in multiple organs leads to the diagnosis of disseminated NTM. This case indicates that, for prompt and accurate diagnosis, efforts to detect specific lesions by an imaging study and to confirm diagnosis pathologically are equally important, especially when local cytology is not convincing. The clinical course of this case may serve as a useful reference in the diagnosis and treatment of NTM.
• Reproductive Outcome of Infertile Patients with Fibroids Based on the Patient and Fibroid Characteristics; Optimal and Personalized Management

  Isao Tsuji; Nahoko Fujinami; Yasushi Kotani; Takako Tobiume; Masato Aoki; Kosuke Murakami; Akiko Kanto; Hisamitsu Takaya; Masayo Ukita; Masao Shimaoka; Hidekatsu Nakai; Ayako Suzuki; Masaki Mandai

  GYNECOLOGIC AND OBSTETRIC INVESTIGATION KARGER 81 (4) 325 - 332 0378-7346 2016 [Refereed]
   

  Aims: To analyze the detailed clinical course of infertile patients with uterine fibroids and to identify optimal and personalized treatment based on the patient or fibroid characteristics. Methods: Retrospective analysis of a case series was performed on 176 infertile patients with fibroids. The patients were classified into different groups according to different treatments (conservative infertility treatment, myomectomy and non-myomectomy surgery). Patient or fibroid characteristics for different groups were analyzed for a possible correlation with the reproductive outcome. Results: The cumulative pregnancy rates by conservative treatment plateaued in 1 year. Myomectomy improved the reproductive outcome in patients who did not conceive with conservative infertility treatments. The most important determinant of the reproductive outcome in patients by conservative treatment prior to surgery was a past patient history of pregnancy. The most important determinant of the reproductive outcome after myomectomy was patient age. Conclusion: Myomectomy should be considered when infertile patients with fibroids do not conceive within 1 year of conservative infertility treatments. The most important determinant of reproductive outcome after myomectomy is patient age. Therefore, for patients younger than 40, the treatment schedule should be carefully considered so that the patients can sufficiently benefit from myomectomy and assisted reproductive technology. (C) 2015 S. Karger AG, Basel
• 腹腔鏡下子宮筋腫核出術時に破損した把持鉗子の回収に苦慮した1例

  浮田 真沙世; 小谷 泰史; 飛梅 孝子; 辻 勲; 中井 英勝; 島岡 昌生; 高矢 寿光; 村上 幸祐; 青木 稚人; 鈴木 彩子; 万代 昌紀

  日本産科婦人科内視鏡学会雑誌 (一社)日本産科婦人科内視鏡学会 31 (1) 170 - 172 1884-9938 2015/11 [Refereed]
   

  症例は41歳女性、0経妊であった。子宮筋腫に対し子宮動脈塞栓術(UAE)の既往があり、UAE施行後、一時的に子宮筋腫は縮小したが5年後、筋腫が増大傾向を認めた。筋腫は子宮底部に存在し径20cmでGnRHa療法5クール施行で径17cmまで軽度縮小した。腹腔鏡下子宮筋腫核出術(LM)を施行し、クローズド法で気腹を行いポートIはパラレル法で行った。子宮筋層にバソプレシン投与後、超音波メスで子宮筋層を切開し筋腫核を露出させた。筋層剥離終了後、筋腫を核出したところで、把持鉗子の先端がスムーズに開かないことに気付き、先端のリベットが脱落していることが判明した。ビデオで腹腔内でリベットが脱落した状態であったことを確認し、術中の破損が判明した。
• 内視鏡技術認定医を目指す修練医が腹腔鏡下子宮筋腫核出術を安全に行うための適応についての検討

  高矢 寿光; 小谷 泰史; 青木 稚人; 村上 幸祐; 浮田 真沙世; 島岡 昌生; 飛梅 孝子; 中井 英勝; 辻 勲; 鈴木 彩子; 万代 昌紀

  日本産科婦人科内視鏡学会雑誌 (一社)日本産科婦人科内視鏡学会 31 (1) 136 - 140 1884-9938 2015/11 [Refereed]
   

  1995年1月〜2014年6月に腹腔鏡下子宮筋腫核出術(LM)症例を対象に、孤発性の筋腫の出血量、手術時間と筋腫核出時の手術操作との関連性について検討した。70例について最大筋腫核径、手術時間と出血量について相関関係を検討したところ、最大筋腫核径と出血量、手術時間と出血量のいずれにおいても正の相関関係が認められた。術者別に検討したところ、内視鏡技術認定医が執刀した症例が35例、修練医が執刀した症例が35例であった。修練医がLMを行う際には筋腫核径7cm以下の孤発例では輸血等の危険を冒すことなく安全に手技に取り組むことが可能で、このような症例で十分に技術を習得すべきと考えられた。一方、腫瘍径8cm以上の症例においては内視鏡技術認定医でも500ml以上の出血をきたす例があり、また、核出時間がより出血量と相関するという今回の結果から、縫合操作のみならず核出操作にも習熟する必要があると思われた。
• Erythropoietin Receptor Antagonist Suppressed Ectopic Hemoglobin Synthesis in Xenografts of HeLa Cells to Promote Their Destruction

  Yoshiko Yasuda; Mitsugu Fujita; Eiji Koike; Koshiro Obata; Mitsuru Shiota; Yasushi Kotani; Terunaga Musha; Sachiyo Tsuji-Kawahara; Takao Satou; Seiji Masuda; Junko Okano; Harufumi Yamasaki; Katsumi Okumoto; Tadao Uesugi; Shinichi Nakao; Hiroshi Hoshiai; Masaki Mandai

  PLOS ONE PUBLIC LIBRARY SCIENCE 10 (4) e0122458  1932-6203 2015/04 [Refereed]
   

  The aim of this study is to explore a cause-oriented therapy for patients with uterine cervical cancer that expresses erythropoietin (Epo) and its receptor (EpoR). Epo, by binding to EpoR, stimulates the proliferation and differentiation of erythroid progenitor cells into hemoglobin-containing red blood cells. In this study, we report that the HeLa cells in the xenografts expressed epsilon,gamma, and a globins as well as myoglobin (Mb) to produce tetrameric alpha 2 epsilon 2 and alpha 2 gamma 2 and monomeric Mb, most of which were significantly suppressed with an EpoR antagonist EMP9. Western blotting revealed that the EMP9 treatment inhibited the AKT-pAKT, MAPKs-pMAPKs, and STAT5-pSTAT5 signaling pathways. Moreover, the treatment induced apoptosis and suppression of the growth and inhibited the survival through disruption of the harmonized hemoprotein syntheses in the tumor cells concomitant with destruction of vascular nets in the xenografts. Furthermore, macrophages and natural killer (NK) cells with intense HIF-1 alpha expression recruited significantly more in the degenerating foci of the xenografts. These findings were associated with the enhanced expressions of nNOS in the tumor cells and iNOS in macrophages and NK cells in the tumor sites. The treated tumor cells exhibited a substantial number of perforations on the cell surface, which indicates that the tumors were damaged by both the nNOS-induced nitric oxide (NO) production in the tumor cells as well as the iNOS-induced NO production in the innate immune cells. Taken together, these data suggest that HeLa cells constitutively acquire e,. and Mb synthetic capacity for their survival. Therefore, EMP9 treatment might be a cause-oriented and effective therapy for patients with squamous cell carcinoma of the uterine cervix.
• 当科における初期子宮体癌に対する腹腔鏡下手術の導入と安全性・術後ADLの検討

  高矢 寿光; 小谷 泰史; 青木 稚人; 村上 幸祐; 浮田 真沙世; 島岡 昌生; 飛梅 孝子; 中井 英勝; 辻 勲; 鈴木 彩子; 万代 昌紀

  日本産科婦人科内視鏡学会雑誌 (一社)日本産科婦人科内視鏡学会 30 (2) 414 - 420 1884-9938 2015/03 [Refereed]
   

  初期子宮体癌に対する腹腔鏡下手術の導入と安全性・術後ADLについて検討した。腹腔鏡下子宮体癌根治術を施行した10例を対象とした。平均手術時間273.9分、平均出血量40g、平均摘出リンパ節数21.6個であった。術中合併症は認めず、輸血症例もなかった。初回歩行は全例で術翌日から開始し、食事開始は6例で術翌日から開始できた。周術期合併症は1例で術後リンパ嚢胞への感染を認め、治療を要したため、術後在院日数が2週間以上となったが、それ以外は1週間前後であった。術前の病理学的所見は、全例が類内膜腺癌G1またはG2であったが、術後1例が類内膜腺癌G3の診断となった。リンパ節転移は認めなかったが、1例で卵巣への顕微鏡的な転移を認めた。1例で著明な静脈侵襲を認め、術後補助化学療法を施行した。腹水細胞診は3例で陽性であったが、他のリスク因子がない場合は術後治療は行わなかった。
• Long-term survival in metastatic malignant struma ovarii treated with oral chemotherapy: A case report

  Masayo Ukita; Hidekatsu Nakai; Yasushi Kotani; Takako Tobiume; Eiji Koike; Iso Tsuji; Ayako Suzuki; Masaki Mandai

  ONCOLOGY LETTERS SPANDIDOS PUBL LTD 8 (6) 2458 - 2462 1792-1074 2014/12 [Refereed]
   

  Malignant struma ovarii is a rare type of ovarian tumor. Metastasis from malignant struma ovarii is rare and has only been documented in 5-6% of cases. The natural history and optimal treatment strategy for malignant struma ovarii remains controversial due to its rarity. The current report presents the case of a 45-year-old female who presented with a tumor of the rib bone. Following resection, the postoperative diagnosis was a metastasizing thyroid carcinoma. No abnormality was detected in the thyroid gland, however, computed tomography revealed a tumor in the left ovary. The patient underwent a left salpingo-oophorectomy and a wedge resection of the right ovary. The postoperative diagnosis was determined as a mature cystic teratoma with malignant struma ovarii (thyroid type, follicular carcinoma) of the left ovary and mature cystic teratoma of the right ovary. Four years subsequent to the initial diagnosis, multiple lung metastases were detected. The following chemotherapies were administered sequentially and intermittently: Tegafur-uracil, paclitaxel/carboplatin and oral etoposide. During this period, the metastatic lesions extended into the bone and progressed slowly. The patient continues to survive with the disease and 24 years have passed since the initial diagnosis, 20 years following the diagnosis of multiple lung metastates. The present report describes a rare case of malignant struma ovarii in which surgical resection and pathological examination of a metastatic rib tumor resulted in the identification of the primary ovarian lesion. The clinical behavior of malignant struma ovarii does not necessarily indicate a histological malignancy, therefore, prediction of future metastasis is difficult and the optimal treatment strategy for malignant struma ovarii is controversial. The present case indicates that the long-term use of oral anticancer agents may facilitate the maintenance of tumor dormancy.
• Introduction of Total Laparoscopic Hysterectomy as a Substitute for Laparoscopically Assisted Vaginal Hysterectomy: A Comparison of the First 23 Cases

  Eiji Koike; Yasushi Kotani; Takako Tobiume; Isao Tsuji; Hidekatsu Nakai; Masayo Ukita; Ayako Suzuki; Masahiko Umemoto; Mitsuru Shiota; Masaki Mandai

  Gynecology & Obstetrics 4 1 - 4 2014/04 [Refereed]
  
• Ovarian tumor cases that were preoperatively diagnosed as benign but postoperatively confirmed as borderline or malignant after laparoscopic surgery

  Yasushi Kotani; Masahiko Umemoto; Takako Tobiume; Mitsuru Shiota

  Gynecology and Minimally Invasive Therapy 2 (4) 122 - 125 2213-3070 2013/11 [Refereed]
   

  Objective: Laparoscopic surgery is the gold standard for benign ovarian tumors because of its overall improved quality of life (QOL). However, some tumors diagnosed preoperatively as benign may be proven to be malignant by postoperative studies. The standard approach for the removal of a malignant ovarian tumor in our hospital is via laparotomy however, there is no referential prognostic data on malignancies that are excised laparoscopically. To evaluate clinical and histological factors and prognosis, this study retrospectively reviewed patients who underwent surgery in our hospital, based on a preoperative diagnosis of benignancy, but later postoperative testing proved their tumors to be borderline or malignant. Participants and methods: The study group comprised 1322 women who underwent a laparoscopic procedure in our hospital on the basis of a preoperative diagnosis of a benign ovarian tumor. The procedures were performed between 1995 and 2011. The rate of borderline and malignant cases, histology, and postoperative treatment were investigated. Results: Of the 1322 patients, 15 (1.1%) patients were postoperatively diagnosed as having a borderline malignancy with various histological types and all of these patients had a good prognosis four (0.3%) patients were postoperatively diagnosed as having a malignant tumor with various histological types of these patients, two patients required emergency surgery. All four patients underwent additional surgery and chemotherapy with no recurrence to date. Conclusion: Some tumors diagnosed preoperatively as benign proved postoperatively to be malignant. Appropriate postoperative treatment effectively improved the prognosis. Particular attention should be paid to a possible occult malignancy that may manifest postoperatively, especially in patients who underwent emergency surgery. We recommend preoperative magnetic resonance imaging, even for emergency cases, to improve preoperative diagnosis. © 2013.
• Uterus-sparing myomectomy for uterine pyomyoma following cesarean section

  Mitsuru Shiota; Yasushi Kotani; Kazumi Ami; Yoshiaki Mizuno; Yuka Ekawa; Masahiko Umemoto

  TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY ELSEVIER TAIWAN 52 (1) 140 - 141 1028-4559 2013/03 [Refereed]
  
• Preoperative differentiation between tumor-related ovarian torsion and rupture of ovarian cyst preoperatively diagnosed as benign: A retrospective study

  Mitsuru Shiota; Yasushi Kotani; Masahiko Umemoto; Takako Tobiume; Hiroshi Hoshiai

  Journal of Obstetrics and Gynaecology Research 39 (1) 326 - 329 1341-8076 2013/01 [Refereed]
   

  Introduction: Patients with ovarian cyst sometimes present with acute abdomen caused by ovarian torsion or rupture, which are difficult to differentiate preoperatively. The purpose of this study was to determine preoperative features of patients with ovarian cyst that could be used in differentiation. Material and Methods: Among 1723 patients with a preoperative diagnosis of benign ovarian cyst who underwent surgery between 1995 and 2010, 77 patients with ovarian torsion and 21 patients with ruptured ovarian cyst were retrospectively evaluated. The mean preoperative age, serum C-reactive protein (CRP) level, white blood cell count, body temperature, cyst size, and rate of acute abdomen were compared between the two groups, and postoperative pathological data were also collected. Results: There were significant differences between the torsion and rupture groups in the mean preoperative CRP levels (0.9 mg/dL vs 6.6 mg/dL, respectively P < 0.01) and in the mean ovarian cyst sizes (9.7 cm vs 6.7 cm, respectively P = 0.04). Conclusion: In this study, the patients with ruptured ovarian cyst had elevated CRP levels. Another study has demonstrated that there was risk for necrosis in torsion patients with elevated CRP levels who presented more than 10 h after the onset of acute abdomen. Therefore, preoperative differential diagnosis between ovarian torsion and rupture may be possible by combining the findings from preoperative imaging, data on the time from onset of acute abdomen, and CRP values. © 2012 The Authors.
• A patient with severe endometriosis treated with long-term GnRHa: case report.

  Yasushi Kotani; Mitsuru Shiota; Masahiko Umemoto; Takako Tobiume; Koshiro Obata; Hiroshi Hoshiai

  Acta Medica Kinki University Kinki University Medical Association 37 (2) 99 - 101 0386-6092 2012/12 [Refereed]
   

  [Abstract] Gonadotrophin-releasing hormone agonist (GnRHa) therapy for endometriosis is rarely used for long periods of time because it leads to decreased bone density and menopausal syndrome. Here, we describe a patient with severe endometriosis who underwent a colostomy and hysterectomy at a young age and has been on GnRHa therapy for 13 years since the surgery. The patient is a 37-year-old G0P0 woman who underwent a colostomy for ileus of the sigmoid colon and rectal endometriosis at the age of 21 years. At the age of 22 years, she underwent total abdominal hysterectomy, chocolate cystectomy, and partial rectectomy. After the surgery, her ovarian endometrioma recurred and ureteral endometriosis developed. She was then started on GnRHa therapy and has been on continuous therapy for 13 years up to the present. Side effects as such as decreased bone mineral density and menopausal syndrome have not been observed. Although GnRHa therapy is generally not used chronically because of its side effects, it has been possible to use it in this patient over a long period of time by ongoing monitoring for the development of deleterious side effects and adjusting the dose as needed.
• Standardization of laparoscopically assisted vaginal hysterectomy for uterine myoma and uterine adenomyosis at a single institution

  Kikuko Okada; Mitsuru Shiota; Yasushi Kotani; Masahiko Umemoto; Takako Tobiume; Natsuki Ugajin; Hiroshi Hoshiai

  Japanese Journal of Gynecologic and Obstetric Endoscopy JAPAN SOCIETY OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY AND MINIMALLY INVASIVE THERAPY 28 (1) 426 - 432 1884-9938 2012/08 [Refereed]
   

  Objective: Total vaginal hysterectomy (TVH) and total abdominal hysterectomy (TAH) are presently the standard procedures for total hysterectomy. Since the advent of laparoscopically assisted vaginal hysterectomy (LAVH), our institution has actively performed LAVH to establish it as standardized procedure for patients with uterine myomas and those with uterine adenomyosis. This report investigates the parameters to determine LAVH to be considered a standardized procedure.
  Method: In our institution, 282 LAVH cases were performed from 1995 to 2001 (Group I), 258 cases from 2002 to 2010 (Group IIa) by "experts", and 83 cases by non-expert Ob/Gyn surgeon (Group IIb). The groups were compared by age and parity of the patients; uterine weight; operative time; blood loss; rates of intraoperative conversion to open surgery; and intra- and post-operative complications. The trend in the annual rate of LAVH was also examined.
  Results: There were no significant differences in age, parity, blood loss, or conversion to open surgery. Uterine weight was significantly lower (350g) and operative time significantly longer (163min) in Group IIb than in Groups I (400g/143min) and IIa (411g/143min). The annual LAVH rate has increased continually, from 16.2% in 1995 to 85.7% in 2010.
  Discussion: Because no difference was observed in blood loss or complication rates among the three groups of patients, the authors have concluded that LAVH can be performed by all gynecological surgeons. Presently, LAVH is performed for the majority of patients requiring total hysterectomy. Therefore, LAVH has been established as the institution's standardized procedure for total hysterectomy.
• Estimation of preoperative uterine weight in uterine myoma and uterine adenomyosis

  Mitsuru Shiota; Yasushi Kotani; Masahiko Umemoto; Takako Tobiume; Hiroshi Hoshiai

  Asian Journal of Endoscopic Surgery 5 123 - 125 2012/08 [Refereed]
  
• Clinical indices and histological changes over time in ovarian torsion related to ovarian tumors

  Mitsuru Shiota; Yasushi Kotani; Masahiko Umemoto; Takako Tobiume; Hiroshi Hoshiai

  Gynecological Surgery 9 347 - 350 2012/03 [Refereed]
  
• Study of the correlation between tumor size and cyst rupture in laparotomy and laparoscopy for benign ovarian tumor: Is 10 cm the limit for laparoscopy?

  Mitsuru Shiota; Yasushi Kotani; Masahiko Umemoto; Takako Tobiume; Hiroshi Hoshiai

  JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH WILEY-BLACKWELL 38 (3) 531 - 534 1341-8076 2012/03 [Refereed]
   

  Aim: Laparoscopy is the gold standard for treatment of benign ovarian cysts, although there is a risk of intraoperative cyst rupture if the lesion is cancerous. This study is aimed at comparing the incidence of cyst rupture to tumor size in both laparotomy and laparoscopy in order to select the optimum surgical procedure for ovarian cysts. Methods: A total of 1483 cases of benign ovarian cysts were surgically treated at our center between 1995 and 2010. These cases were divided into three groups according to the maximum diameter of the ovarian tumors: < 5 cm, >= 5 cm but < 10 cm, and >= 10 cm. The incidence of cyst rupture was compared between laparotomy and laparoscopy according to the size of the tumor in ovarian tumorectomy and adnexectomy. Results: The incidence of cyst rupture was significantly higher in ovarian tumorectomy by laparoscopy than by laparotomy. Cyst rupture occurred independent of the tumor size in both laparoscopy and laparotomy. For adnexectomy for tumors smaller than 10 cm, there was no significant difference by tumor size in the incidence of cyst rupture between laparoscopy and laparotomy; however, the incidence of cyst rupture was significantly higher in laparoscopy of tumors sized 10 cm or larger than in the laparotomy of tumors of similar size; the incidence was also greater than laparoscopy of tumors smaller than 10 cm. Conclusion: Laparotomy, rather than laparoscopy, is recommended in cases of ovarian cysts with any finding suggestive of malignancy.
• 子宮筋腫核出術後の妊娠予後規定因子に関する検討

  辻 勲; 網 和美; 宮崎綾子; 藤浪菜穂子; 小谷泰史; 飛梅孝子; 梅本雅彦; 塩田 充; 星合 昊

  日本受精着床学会雑誌 29 118 - 121 2012/03 [Refereed]
  
• A study of cyst rupture rate by tissue type in open vs. laparoscopic surgery for ovarian tumor

  Masahiko Umemoto; Mitsuru Shiota; Takako Tobiume; Yasushi Kotani; Hiroshi Hoshiai

  Gynecological Surgery 9 (1) 107 - 109 1613-2076 2012/02 [Refereed]
   

  Laparoscopy may be suitable for benign ovarian tumors, but the risk of intraoperative cyst rupture may carry serious consequences should the lesion prove cancerous postoperatively. Incidence of cyst rupture may be related to lesion tissue type however, to our knowledge, no study to date has evaluated it by tissue type. We report herein a comparative retrospective study of open surgery and laparoscopy on cyst rupture by tissue type. A total of 1,483 cases of surgical removal of benign ovarian tumor performed at our institution between 1995 and 2010 were reviewed. Cyst rupture rates during open surgery and laparoscopy were compared for tumorectomy and adnexectomy for the four most frequent tissue types found at postoperative histopathology: endometrial cyst, mature cystic teratoma, serous cystadenoma, and mucinous cystadenoma. Data collected for our study demonstrated that cyst rupture rates are higher in laparoscopy than in open surgery regardless of tissue type. Rupture rates were significantly higher during laparoscopic tumorectomy, while there was no significant difference overall in rupture rate for open vs. laparoscopic adnexectomy. Laparoscopic procedures should be performed with utmost care to avoid cyst rapture when malignancy cannot be ruled out. A high risk of cyst rapture preoperatively expected by tissue type dictates an open surgery. © 2011 Springer-Verlag.
• Incidence of complications in patients with benign gynecological diseases by BMI and level of complexity of laparoscopic surgery

  Mitsuru Shiota; Yasushi Kotani; Masahiko Umemoto; Takako Tobiume; Hiroshi Hoshiai

  Asian Journal of Endoscopic Surgery 5 17 - 20 2012/02 [Refereed]
  
• Reversible Posterior Leukoencephalopathy Syndrome Accompanying Eclampsia: Correct Diagnosis Using Preoperative MRI

  Yuka Ekawa; Mitsuru Shiota; Takako Tobiume; Masao Shimaoka; Mitsuhiro Tsuritani; Yasushi Kotani; Yoshiaki Mizuno; Hiroshi Hoshiai

  TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE TOHOKU UNIV MEDICAL PRESS 226 (1) 55 - 58 0040-8727 2012/01 [Refereed]
   

  Reversible posterior leukoencephalopathy syndrome (RPLS) is characterized by clinical symptoms such as seizures, visual disturbance, and altered mental status. It also presents abnormal findings on computed tomography (CT) and magnetic resonance imaging (MRI) indicating cerebral edema in the white matter of the occipital, temporal, and parietal lobes. Both the clinical symptoms and abnormal imaging findings can be reversed by controlling blood pressure or treating the underlying condition including infection. This report describes a patient with RPLS that occurred secondary to eclampsia. A 26-year-old female, gravida 0 para 0, developed weakness and pain in her upper and lower extremities and gait disturbance during the 34th week of pregnancy, and severe pregnancy-induced hypertension near the end of the 37th week. On the first day of the 38th week, she developed constricted visual fields and complained of visual illusions. MRI revealed a high-signal-intensity area in the right occipital lobe. Immediately after MRI, the patient had a 10-sec tonic convulsion. Diagnosed with eclampsia, she underwent emergency cesarean section. MRI on the 2nd postoperative day showed that the high-signal-intensity area was slightly improved. Her visual illusions were diminished by the 4th postoperative day, and almost all subjective symptoms disappeared by the 7th postoperative day. The patient was discharged at 12th postoperative day. We recommend MRI not only for symptomatic patients with suspected RPLS, but also for asymptomatic patients with severe pregnancy-induced hypertension. If findings such as cerebral edema are observed on MRI, immediate delivery should be considered before eclamptic seizures or exacerbation of neurological symptoms.
• Recurrence of uterine myoma after laparoscopic myomectomy: What are the risk factors?

  Mitsuru Shiota; Yasushi Kotani; Masahiko Umemoto; Takako Tobiume; Hiroshi Hoshiai

  Gynecology and Minimally Invasive Therapy Elsevier B.V. 1 (1) 34 - 36 2213-3089 2012 [Refereed]
   

  Objective: Uterine myoma is a common gynecologic disease. Myomectomy is selected to preserve the uterus, and with recent advances in laparoscopic technology, laparoscopic myomectomy (LM) has become a common treatment. However, myoma can recur after LM, and to date, reports on post-LM recurrence rates and risk factors have been inconsistent. This retrospective study examines post-LM recurrence rates and the possible risk factors for recurrence. Materials and Methods: Between 1995 and 2010, 250 patients who underwent LM at a single institution were followed from the postoperative sixth month to the fifth year semiannually for recurrence by ultrasound/magnetic resonance imaging (MRI). Mean age, body mass index (BMI), preoperative gonadotropin-releasing hormone agonist (GnRHa) therapy, surgical time, blood loss, number of removed myomas, and largest myoma diameter were compared between patients with recurrence and those without. Recurrence rates were also investigated by individual risk factors, including patient age, GnRHa therapy, number of removed myomas, and largest tumor diameter. Results: Cumulative post-LM recurrence rates were 15.3%, 43.8%, and 62.1% at postoperative years 1, 3, and 5, respectively. There were significant differences in surgical time, blood loss, and number of removed myomas between patients with recurrence and those without. Analysis of risk factors revealed significant correlation between recurrence rates and patient age, number of myomas, and myoma size. Conclusion: Risk of post-LM recurrence increases over time. Risk factors are age, myoma size, and number of tumors. Particular attention to recurrence is required for patients with uterine myomas of ≥10 cm diameter, with numerous myomas, and those age 35 years or older. © 2012.
• Laparoscopic versus open surgery for pregnancy complicated by benign ovarian tumor

  Yasushi Kotani; Mitsuru Shiota; Masahiko Umemoto; Takako Tobiume; Mitsuhiro Tsuritani; Masao Shimaoka; Yoshiaki Mizuno; Yuka Ekawa; Hiroshi Hoshiai

  Japanese Journal of Gynecologic and Obstetric Endoscopy JAPAN SOCIETY OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY AND MINIMALLY INVASIVE THERAPY 27 (2) 489 - 494 1884-9938 2011/12 [Refereed]
   

  Objective
    Ovarian tumor is reported to complicate 1% to 4 % of all pregnancies. Laparoscopic surgery is currently the gold standard for benign ovarian tumors because it is a minimally invasive procedure. However, the effects of laparoscopic surgery on the fetus from anesthesia, surgical infection, and pneumoperitoneum are unknown. This retrospective study compared operative results and pregnancy outcomes of laparoscopic and open surgeries performed for pregnancies complicated by benign ovarian tumor.
  Method
    This study included 59 patients (23 laparoscopy and 36 open surgery cases) with a preoperative diagnosis of benign ovarian tumor, who underwent surgery between January 1993 and December 2010. Patient characteristics, operative results, intraoperative cyst rupture rate, postoperative pathology, pregnancy outcome including fetal status at delivery were compared between laparoscopic and open surgery groups.
  Results
    The mean blood loss and duration of postoperative hospitalization in the laparoscopy group were 22 ± 34 mL and 6.0 ± 2.7 days, respectively, and in the open surgery group were 102 ± 99 mL and 11.6 ± 2.9 days, respectively, which were significant (P < 0.05 and P < 0.01, respectively). No significant difference was found in the mean number of weeks of gestation or the mean infant birth weight (3131 g in laparoscopy group vs 3071 g in the open surgery group including one threatened premature labor). Both groups included no fetal anomaly.
  Conclusion
    Laparoscopic surgery is a safe procedure for pregnancy complicated by benign ovarian tumor, providing better or comparable results with respect to adverse effects, blood loss, duration of hospitalization, cyst rupture rate, and pregnancy outcome compared with open surgery.
• Incidental Detection of Breast Apocrine Carcinoma via Endometrial Cytology

  Mitsuru Shiota; Yasushi Kotani; Masahiko Umemoto; Takako Tobiume; Hiroshi Hoshiai

  TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE TOHOKU UNIV MEDICAL PRESS 225 (4) 235 - 237 0040-8727 2011/12 [Refereed]
   

  Breast apocrine carcinoma is a rare malignancy characterized histologically by a predominance of acidophilic tumor cells exhibiting apocrine metaplasia. Apocrine tumors represent only about 0.4% of all breast cancers. Many cases are diagnosed at stage I or II; thus, the prognosis is better than that for other types of breast cancer. Here we present a 57-year-old female patient with primary apocrine breast carcinoma that was incidentally discovered by endometrial cytology. The patient had undergone routine uterine cancer screening at the age of 56 with resulting positive endometrial cytology. Subsequent histological examination of an endometrial biopsy revealed suspected metastatic uterine adenocarcinoma. Further evaluation revealed a 3-cm mass in the left breast, which was histopathologically diagnosed as breast cancer. Dual procedures were performed at the departments of gynecology and breast surgery. The patient underwent a modified radical mastectomy of the left breast and left axillary lymph node dissection. Laparotomy revealed multiple adhesions throughout the peritoneal cavity that suggested invasive metastatic cancer, and a right adnexectomy was performed. Histopathological examination of the resected left breast and right ovary tissues revealed apocrine carcinoma. Thus, stage IV breast cancer was diagnosed. The patient finished 6 cycles of paclitaxel and is now under observation on an outpatient basis. In this patient, breast cancer was discovered incidentally through a detailed work-up after a positive result of endometrial cytology. Uterine cancer screening has the potential, although rare, to detect metastatic cancer originating elsewhere. This should be taken into consideration during the work-up due to positive endometrial cytology.
• 当科における子宮鏡手術の合併症に関する検討

  小谷泰史; 小池英爾; 梅本雅彦; 飛梅孝子; 宮崎綾子; 宇賀神奈月; 小畑孝四郎; 塩田 充; 星合 昊

  日本産科婦人科内視鏡学会雑誌 27 473 - 477 2011/12 [Refereed]
  
• Water intoxication presenting as hyponatremia during hysteroscopic myomectomy: A case report

  Koike Eiji; Kotani Yasushi; Umemoto Masahiko; Tobiume Takako; Miyazaki Ayako; Ugajin Natsuki; Shiota Mitsuru; Hoshiai Hiroshi

  JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY JAPAN SOCIETY OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY AND MINIMALLY INVASIVE THERAPY 27 (2) 425 - 428 1884-9938 2011/12 [Refereed]
   

  Hysteroscopic myomectomy is indicated for symptomatic submucosal uterine fibroids. The main complications associated with the procedure are uterine perforation and water intoxication. This report details a case of water intoxication that presented with acute hyponatremia during hysteroscopic myomectomy. The procedure was suspended and the patient's electrolyte imbalance was managed in the intensive care unit (ICU).
    The patient was a 36-year-old nulligravid female with a history of hypermenorrhea and a 6cm submucosal myoma with 100% protrusion from the uterine fundus. Excision of the tumor by laparoscopy combined with hysteroscopic myomectomy was attempted to preserve the uterus. At three hours and thirty minutes into the procedure, the patient's blood pressure dropped to 70/40mmHg. Infusion volume was 15,000ml and drainage was 12,000ml. An immediate electrolyte panel revealed severe hyponatremia, with a serum sodium level of 96mEq/l. The operation was suspended and the patient was transferred to the ICU. She left the ICU the next day with a serum sodium level of 132mEq/l. On the 6th post-operative day, she was discharged without significant sequelae. The size of the remaining myoma on follow-up ultrasound was 3cm, but a repeat hysteroscopy revealed that the intrauterine protrusion had receded. After six months, the patient underwent open myomectomy.
    This case suggests that operative duration in hysteroscopy should be less than 2 hours to avoid water intoxication. In addition, infusion and drainage volumes must be monitored, with special attention required when the difference between the two volumes exceeds 750ml. The operation should be suspended when the difference exceeds 1500ml.
• Predictive Factors for Ovarian Necrosis in Torsion of Ovarian Tumor

  Takako Tobiume; Mitsuru Shiota; Masahiko Umemoto; Yasushi Kotani; Hiroshi Hoshiai

  TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE TOHOKU UNIV MEDICAL PRESS 225 (3) 211 - 214 0040-8727 2011/11 [Refereed]
   

  Most cases of ovarian torsion require emergency surgery; the ovary has become necrotic and cannot be conserved. Preoperative determination of the ovarian necrosis extent is difficult but it may increase the likelihood of the ovary conservation. In this study, we retrospectively evaluated the findings in ovarian torsion among patients with ovarian tumors who underwent emergency surgery at a single hospital for possible preoperative indicators of ovarian viability. We thus evaluated 77 patients who were intraoperatively diagnosed with torsion of ovarian tumor between 1995 and 2010. These patients were classified into three groups depending on the postoperative histopathological findings: necrotic, congestive, and normal. Preoperative C-reactive protein (CRP) level, leukocyte count, and body temperature, along with tumor size, degree of torsion, time from the onset of abdominal pain to surgery, and incidence of acute abdomen were compared among the three groups. The sensitivity, specificity, and positive and negative predictive values of the preoperative serum CRP levels for ovarian necrosis were calculated. The CRP level, degree of torsion, and time from the onset of abdominal pain to surgery were significantly higher in the necrotic group than in the normal group. The sensitivity and specificity of the CRP level for necrosis were 35% and 83%, respectively, and positive and negative predictive values were 38% and 82% respectively. The potential for ovary conservation in suspected ovarian torsion should be greater if the tumor is non-malignant, the time from the onset of abdominal pain to operation is short, and the CRP level is <0.3 mg/dl.
• Total abdominal hysterectomy versus laparoscopically-assisted vaginal hysterectomy versus total vaginal hysterectomy

  Mitsuru Shiota; Yasushi Kotani; Masahiko Umemoto; Takako Tobiume; Masao Shimaoka; Hiroshi Hoshiai

  Asian Journal of Endoscopic Surgery 4 161 - 165 2011/11 [Refereed]
  
• Risk Factors for Deep-Vein Thrombosis and Pulmonary Thromboembolism in Benign Ovarian Tumor

  Mitsuru Shiota; Yasushi Kotani; Masahiko Umemoto; Takako Tobiume; Mitsuhiro Tsuritani; Masao Shimaoka; Hiroshi Hoshiai

  TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE TOHOKU UNIV MEDICAL PRESS 225 (1) 1 - 3 0040-8727 2011/09 [Refereed]
   

  Pulmonary thromboembolism (PE) is a serious postoperative complication. Reported rates of PE following gynecologic surgery are between 0.3% and 0.8%, with deep-vein thrombosis (DVT) as the major cause (via seeding of the lungs). Benign ovarian tumors are treated principally by surgery. Possible risk factors for DVT and PE in patients with benign ovarian tumors include tumor size, patient age, and obesity. To date, however, there has been no report addressing the association of these risk factors in patients with benign ovarian tumors. This study offers a retrospective analysis of the incident of preoperative DVT by age, tumor size, and BMI in patients undergoing surgery for benign ovarian tumors. A total of 843 Japanese patients with a preoperative diagnosis of benign ovarian tumor who underwent tumorectomy or adnexectomy at our institution between July 2003 and December 2010 were enrolled. The incidence of preoperative DVT was monitored and statistically stratified by age (< 50 years and >= 50 years), largest tumor diameter (< 10 cm and >= 10 cm), and BMI (< 25 and >= 25). The result indicates that tumor diameter of >= 10 cm is not a risk factor for preoperative DVT in patients with benign ovarian tumor. On the other hand, age >= 50 years and BMI > 25 are independent risk factors for preoperative DVT in Japan. The patients with each risk factor should be treated with preoperative, intraoperative, and postoperative precautions against development of PE.
• Case of acquired hemophilia with factor VIII inhibitor in a mother and newborn

  Yasushi Kotani; Mitsuru Shiota; Masahiko Umemoto; Eiji Koike; Mitsuhiro Tsuritani; Hiroshi Hoshiai

  JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH WILEY-BLACKWELL 37 (8) 1102 - 1105 1341-8076 2011/08 [Refereed]
   

  We report a mother and newborn in the puerperium with hemorrhage secondary to factor VIII inhibitor. A 31-year-old gravida 1 para 1 delivered at a local clinic with a massive postpartum hemorrhage. The activated partial thromboplastin time was prolonged and factor VIII inhibitor was detected. The persistent hemorrhage improved following treatment, including transfusion, steroid therapy, and bypass therapy with factor VII formulations. After hysteroscopic removal of the retained placenta, the hemorrhage decreased. The newborn developed significant swelling of the hands after routine blood sampling and factor VIII inhibitor was detected. The inhibitor disappeared without any special treatment in the 5th month postpartum in the mother and the 4th month postpartum in the newborn. Factor VIII inhibitor may be transferred via the placenta from the mother to the fetus. Therefore, the newborn should also be carefully observed in a case of massive hemorrhage after delivery.
• Indication for Laparoscopically Assisted Vaginal Hysterectomy

  Mitsuru Shiota; Yasushi Kotani; Masahiko Umemoto; Takako Tobiume; Hiroshi Hoshiai

  JSLS-JOURNAL OF THE SOCIETY OF LAPAROENDOSCOPIC SURGEONS SOC LAPAROENDOSCOPIC SURGEONS 15 (3) 343 - 345 1086-8089 2011/07 [Refereed]
   

  Objectives: Total hysterectomy procedures include total abdominal hysterectomy (TAH), total vaginal hysterectomy (TVH), and laparoscopically assisted vaginal hysterectomy (LAVH). Our institution has introduced LAVH as a preferred option to the more invasive TAH. To date, no reports have proposed surgical indications for LAVH based on statistical analysis of surgical results. The purpose of this study was to establish criteria for performing LAVH through statistical analysis of a retrospective review of surgical outcomes in LAVH cases at our institution over a period of 15 years. Methods: The medical records of 629 patients scheduled for LAVH for uterine fibroids and/or adenomyosis at our hospital were examined. Surgical results (blood loss, operative time, rates of conversion to laparotomy, and intra- and postoperative complications) were compared among 9 groups classified by uterine weight. Results: Statistically significant differences in surgical outcomes were found between the group with a uterine weight >= 800g and the other groups. Conclusion: We found that when the uterine weight was >= 800g, TAH was more appropriate because significant blood loss and/or complications would be expected during LAVH. A removed uterus weighing 800g is reportedly equivalent to a preoperative uterine size of approximately 12cm. Therefore, LAVH may be safely indicated for patients with a uterine size <= 12cm (approximately equivalent to the uterine size at 16-weeks gestation).
• Deep-Vein Thrombosis Is Associated with Large Uterine Fibroids

  Mitsuru Shiota; Yasushi Kotani; Masahiko Umemoto; Takako Tobiume; Mitsuhiro Tsuritani; Masao Shimaoka; Hiroshi Hoshiai

  TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE TOHOKU UNIV MEDICAL PRESS 224 (2) 87 - 89 0040-8727 2011/06 [Refereed]
   

  Pulmonary thromboembolism (PE) may occur upon a patient's first postoperative attempt of ambulation. PE is a serious complication, often leading to shock or sudden death. Reported rates of PE following gynecologic surgery are between 0.3% and 0.8%, while the incidence of postoperative deep-vein thrombosis (DVT), the major cause of PE, is between 17% and 20%. Therefore, effective preventive measures, such as preoperative assesment for asymptomatic DVT, should be considered. It is well known that DVT and/or PE are associated with large uterine fibroids, the common, benign tumor of myometrium. Here, to establish the statistical relationship between DVT risk and uterine fibroid size/weight, we assessed the preoperative DVT rate with respect to three possible risk factors: age, obesity level, and uterine size/weight. A total of 361 patients with uterine fibroids undergoing hysterectomy between July, 2003 and December, 2009 were enrolled. All patients were evaluated for preoperative DVT; the results were stratified for statistical comparison by patient age, BMI, and uterine weight. There was no statistical difference in the DVT rate for patients stratified by age (below age 45 years or older) or BMI (below 25 or higher). By contrast, the rate of DVT was significantly higher for patients with uterine weights of 1,000 gm or more (11.5% [7/61]) compared with weights below 1,000 gm (3.0% [9/300]). None of the patients studied developed PE. In conclusion, the incidence of DVT is significantly higher in cases where uterine weight is 1,000 gm or more (ie, adult head size on pelvic examination).
• Ovarian pregnancy: a report of 3 cases diagnosed and treated laparoscopically

  Takako Tobiume; Mitsuru Shiota; Masahiko Umemoto; Masao Shimaoka; Yasushi Kotani; Hiroshi Hoshiai

  Acta Medica Kinki University The Kinki University Medical Association 35 (2) 109 - 113 0386-6092 2010/12 [Refereed]
   

  [Abstract] Ovarian pregnancy is rare from ectopic gestation, with a reported incidence of 0.7-3.3％ of all ectopic pregnancy. Therefore, we have performed laparoscopic surgery since June 1991, and report 3 cases of ovarian pregnancy treated in our hospital in October 2005. The first case was a 37-year-old woman admitted because of lower abdominal pain suspected as intra-abdominal hemorrhage. Her urine hCG was positive and she underwent laparoscopic surgery with a diagnose of ectopic pregnancy. Bilateral fallopian tubes were normal and an irregular tumor and bleeding were seen in the left ovary. The left ovary including the tumor was resected. The second case was a 33-year-old woman admitted with suspected ovarian bleeding because of intra-abdominal hemorrhage. Urine hCG was positive, so laparoscopy was performed for suspected ectopic pregnancy. Bilateral fallopian tubes were normal, but there was a mass bleeding continuously in the right ovary, which was therefore resected. The third case was a 29-year-old woman admitted because of acute abdomen suspected as intra-abdominal hemorrhage. Urine hCG was positive, there was tenderness on the right side and laparoscopy was performed for suspected ectopic pregnancy. Part of the right ovary and tumor were removed. The above 3 cases demonstrated villi in normal ovarian tissue pathologically. None of these cases had concomitant disease, such as choriocarcinoma. As it is difficult to diagnose preoperatively, we diagnosed ovarian pregnancy intraoperatively and pathological findings postoperatively in these three cases ; however, advances of laparoscopy have made it possible to diagnose and treat intraoperatively before rupture.
• Carbamyl phosphate synthetase deficiency and postpartum hyperammonemia

  Yasushi Kotani; Mitsuru Shiota; Masahiko Umemoto; Mitsuhiro Tsuritani; Hiroshi Hoshiai

  AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY MOSBY-ELSEVIER 203 (1) E10 - E11 0002-9378 2010/07 [Refereed]
   

  Carbamyl phosphate synthetase (CPS) is an enzyme that converts ammonia to carbamyl phosphate in the urea cycle. CPS deficiency is a genetic disorder that causes hyperammonemia because of enzyme activity deficiency. It is primarily diagnosed in neonates and infants and has a poor prognosis. We report an adult woman with CPS deficiency who developed hyperammonemia postpartum.
• Laparoscopic mucin removal for pseudomyxoma peritonei

  Kotani Yasushi

  Journal of the Society Laparoendoscopic Surgeons 14 151 - 152 2010/06
• A long-term follow-up case of intravenous leiomyomatosis treated with anticoagulant therapy following conservative surgery

  Yasushi Kotani; Mitsuru Shiota; Masahiko Umemoto; Takako Tobiume; Eiji Koike; Masao Shimaoka; Hiroshi Hoshiai

  Acta Medica Kinki University The Kinki University Medical Association 35 (1) 49 - 52 0386-6092 2010/06 [Refereed]
   

  An intravenous leiomyomatosis is a benign smooth muscle tumor that develops in a vein. Approximately 200 cases have been reported in the literature thus far ; however, no case has been reported to date of an intravenous leiomyomatosis treated conservatively with anticoagulant therapy that has received longterm follow-up. We here present a case report of patient a 44-year-old G2P2. Hysterectomy and adnexectomy were performed and the uterine vein and internal iliac vein were removed, but the superior-located masses were conserved. Currently, in the 6^ post-operative year, no changes have been detected in the location, size, and property of the remaining masses. In addition, thromboses in the deep vein and along the inferior vena cava were confirmed pre-operatively and anticoagulant therapy has been administered continuously post-operatively. Thus, a thorough pre-operative search for thrombi is required in patients with intravenous leiomyomatosis. Anticoagulant therapy may be necessary for patients with tumor conserved in the IVC following conservative surgery.
• 子宮筋腫合併不妊症における内視鏡手術の意義

  辻 勲; 網 和美; 宮崎綾子; 藤浪菜穂子; 小谷泰史; 飛梅孝子; 梅本雅彦; 塩田 充; 星合 昊

  日本受精着床学会雑誌 27 308 - 312 2010/03 [Refereed]
  
• Emergency Cesarean Section as a Result of Acute Eosinophilic Pneumonia during Pregnancy

  Yasushi Kotani; Mitsuru Shiota; Masahiko Umemoto; Hidekatsu Nakai; Takako Tobiume; Hiromitsu Tsuritani; Masao Shimaoka; Kunihiko Doh; Hiroshi Hoshiai

  TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE TOHOKU UNIV MEDICAL PRESS 219 (3) 251 - 255 0040-8727 2009/11 [Refereed]
   

  Acute eosinophilic pneumonia is a disease of unknown etiology characterized by peripheral blood eosinophilia and pulmonary infiltrative shadows on radiography. Acute eosinophilic pneumonia follows an acute course within 1 week and the symptoms include fever, dyspnea, and cough. Acute eosinophilic pneumonia has a good prognosis and responds promptly to steroid treatments. Here we present a critical case of acute eosinophilic pneumonia during pregnancy, which led to emergency cesarean section because of fetal distress. The patient was a 24-year-old gravida at 34 + 6 weeks gestation, with fever, and an elevated CRP; thus antibiotics were started. At 35 + 1 weeks gestation, cardiotocography (CTG) revealed late decelerations, fetal distress was diagnosed, and an emergency cesarean section was performed. The pre-operative maternal blood gas analysis showed a low PaO2 of 55.7 mmHg and a chest X-ray revealed ground-glass opacities and pleural effusions in the middle lower lung fields bilaterally. A male of 2,336 g in weight was delivered with Apgar scores of 8 and 8 at 1 and 5 min, respectively. Due to the clinical progress and the elevated eosinophil count (532/mu l) in the peripheral blood differential leukocyte count, the diagnosis of acute eosinophilic pneumonia was made. With the administration of oxygen and steroid treatment, the patient's general condition recovered. Both the mother and the baby were discharged on the 10(th) post-operative day and the patient has been leading a normal life with no recurrence for > 3 years since delivery.
• Indications of laproscopic myomectomy and efficacy of preoperative GnRHa therapy

  Yasushi Kotani; Mitsuru Shiota; Masahiko Umemoto; Takako Tobiume; Masao Shimaoka; Hiroshi Hoshiai

  Acta Medica Kinki University The Kinki University Medical Association 34 (1) 27 - 34 0386-6092 2009/06 [Refereed]
   

  Purpose: The purpose of this study was to evaluate indications of laparoscopic myomectomy (LM) and the efficacy of preoperative GnRHa therapy. Methods: Study subjects were 161 patients who underwent LM between 1995 and 2007 at our hospital. Based on surgical performance, indications of LM were discussed in terms of the size and number of myomas. The efficacy of preoperative GnRHa therapy was evaluated by comparing the volume of myomas on MRI images and surgical performances. The recurrence rate after LM was evaluated by comparing the number of myomas confirmed on preoperative MRI and that actually enucleated. Statistical analysis was performed by ANOVA, Student's t-test, χ-square test and the Kaplan-Meier method. For all tests, p＜0.05 was considered significant. Results: The group with myomas ≧10cm showed significant increases in blood loss, operative time, and the rate of conversion to laparotomy compared with groups with smaller myomas. However, the number of myomas was not a factor that affected surgical performance. The myoma volume was reduced as a result of 43％ by preoperative GnRHa therapy without compromising surgical performance. No significant difference was observed on GnRHa therapy in the 4-year cumulative recurrence rate. The recurrence rate was significantly higher in the group in which there was a possiblity that some of myomas were missed and left.Discussion: The indications of LM were considered for myomas ＜10cm but not limited by the number of myomas. The postoperative recurrence rate will decrease if surgery is completed on ensuring no myoma has been overlooked by precisely identifying the preoperative myoma status on MRI. Preoperative GnRHa therapy was considered to be a factor not compromising the surgical performance and recurrence rate, but was effective as a pretreatment for LM to expand the indications.
• Efficacy of preoperative gonadotropin-releasing hormone agonist therapy for laparoscopic

  Yasushi Kotani; Mitsuru Shiota; Masahiko Umemoto; Takako Tobiume; Masao Shimaoka; Hiroshi Hoshiai

  Asian Journal of Endoscopic Surgery 2 24 - 28 2009/04 [Refereed]
  
• Retrospective evaluation of CO(2) laser conization in pregnant women with carcinoma in situ or microinvasive carcinoma.

  Mitsuhiro Tsuritani; Yoh Watanabe; Yasushi Kotani; Taeko Kataoka; Haruhiko Ueda; Hiroshi Hoshiai

  Gynecologic and obstetric investigation KARGER 68 (4) 230 - 3 0378-7346 2009 [Refereed]
   

  BACKGROUND: We evaluated the safety and efficacy of CO(2) laser conization in pregnant women with cervical intraepithelial neoplasia 3/carcinoma in situ (CIN3/CIS) or microinvasive carcinoma (MIC). OBJECTIVES: A total of 49 pregnant women with biopsy-proven CIN3/CIS (30 patients) or MIC (19 patients) were studied. METHODS: Retrospective analysis based on clinical records. RESULTS: Median age and median week of gestation were 31 years (range: 22-39) and 17 weeks (range: 7-33), respectively. The median length of cervix resected by conization, median duration of surgery and median blood loss were 14 mm (range: 5-23), 20 min (range: 7-35) and 78 ml (range: 10-797), respectively. One biopsy-proven CIN3/CIS patient was diagnosed with Federation of Gynecology and Obstetrics (FIGO) Ia2 and 3 biopsy-proven MIC patients were diagnosed with FIGO Ib1 based on conization specimens. A total of 35 patients could be followed until delivery, of which 27 (77.1%) patients delivered transvaginally. Although 8 patients (22.9%) had a cesarean section and 6 patients (17.1%) delivered preterm, no conization-related obstetric complications were observed. CONCLUSION: Since it results in few obstetric complications, CO(2) laser conization within 20 mm of length can be considered a safe procedure for pregnant women.
• Laparoscopic mucin removal in patients with pseudomyxoma peritonei

  Yasushi Kotani; Mitsuru Shiota; Masahiko Umemoto; Takako Tobiume; Eiji Koike; Masao Shimaoka; Yohko Takahashi; Kazumi Kanemura; Ayako Ishizu; Hiroshi Hoshiai

  Journal of the Society of Laparoendoscopic Surgeons SOC LAPAROENDOSCOPIC SURGEONS 13 (2) 203 - 206 1086-8089 2009 [Refereed]
   

  Background and Objectives: Pseudomyxoma peritonei results from ovarian and appendiceal mucinous tumors. Cyst rupture results in intraabdominal mucin accumulation, leading to abdominal distension. No effective treatment has yet been established. Pseudomyxoma peritonei is generally associated with a poor prognosis. In a recent Mayo Clinic report, the 5-year survival rate for this disease was 53% and the 10-year survival rate was 32%, while the Memorial Sloan-Kettering Cancer Center reported 5- and 10-year survival rates of 75% and 10%. Methods and Results: In this report, we describe 4 patients with a laparoscopically confirmed recurrence of pseudomyxoma peritonei who subsequently underwent repeated laparoscopic mucin removal. Conclusion: Because laparoscopic surgery can be performed frequently, it appears that laparoscopic surgery, a minimally invasive procedure, greatly improves the quality of life of patients with pseudomyxoma peritonei. © 2009 by JSLS, Journal of the Society of Laparoendoscopic Surgeons.
• 腹腔鏡下腟式子宮全摘術手術(LAVH)の手術成績におけるBMI(body mass index)の関与に関する研究

  小谷泰史; 梅本雅彦; 飛梅孝子; 島岡昌生; 塩田 充; 星合 昊

  日本産科婦人科内視鏡学会雑誌 24 374 - 378 2008/12 [Refereed]
  
• 子宮筋腫の術前子宮重量推定に関する検討

  飛梅孝子; 梅本雅彦; 小谷泰史; 塩田 充; 星合 昊

  日本産科婦人科内視鏡学会雑誌 24 374 - 378 2008/07 [Refereed]
  

Books etc

• わかりやすい疾患と処方薬の解説 病態・薬物治療編

  小谷泰史; 松村謙臣 (Contributor産科・婦人科疾患 子宮筋腫)アークメディア 2022/03
• OGS NOW basic2 ビギナーとその指導医のために いきなりTLH

  小谷泰史; 村上幸祐; 松村謙臣 (Contributor腹腔鏡補助下腟式単純子宮全摘術（LAVH）)メジカルビュー社 2020/04
• わかりやすい疾患と処方薬の解説 病態・薬物治療編

  小谷泰史; 松村謙臣 (Contributor産科・婦人科疾患 子宮筋腫)アークメディア 2018/03
• 産婦人科手術スタンダード 改定第2版

  万代昌紀; 小谷泰史 (Contributor単純子宮全摘術【4】TLH②)メジカルビュー社 2017/03
• OGS NOW21 婦人科ロボット支援手術

  万代昌紀; 小谷泰史; 鈴木彩子 (Contributor広汎子宮全摘術)メジカルビュー社 2015/02
• OGS NOW21 婦人科ロボット支援手術

  万代昌紀; 小谷泰史; 鈴木彩子 (Contributorロボット手技のトレーニング)メジカルビュー社 2015/02
• OGS NOW11 子宮筋腫 こんなときどうする？

  梅本雅彦; 小谷泰史; 塩田 充 (Contributor巨大筋腫核出術（腹腔鏡）)メジカルビュー社 2012/08
• 産婦人科手術スタンダード

  塩田 充; 小谷泰史 (Contributor付属器摘出術[１])メジカルビュー社 2005/12

Conference Activities & Talks

• 困難症例に対する腹腔鏡下子宮筋腫核出術～術後の癒着軽減を目指したLM攻略法～

  小谷泰史

  第63回日本産科婦人科内視鏡学会学術講演会  2023/09
• 腹腔鏡下子宮腺筋症摘出術における手術成績と術後予後に対する検討～開腹手術との比較検討～

  小谷泰史; 森内 芳; 山本貴子; 宮川知保; 村上幸祐; 川崎 薫; 中井英勝; 松村謙臣

  第63回日本産科婦人科内視鏡学会学術講演会  2023/09
• 技術認定医取得に向けたTLH座談会～試験結果からの今後の対策～  [Invited]

  小谷泰史

  第1回 産婦人科 手術手技座談会  2023/04
• 技術認定医取得に向けて～今年度からの変更点と今後の展望～  [Invited]

  小谷泰史

  第5回兵庫県婦人科内視鏡セミナー  2023/02
• 困難症例に対する腹腔鏡下子宮全摘術  [Invited]

  小谷泰史

  第22回近畿産婦人科内視鏡手術研究会  2023/02
• 骨盤臓器脱に対する腹腔鏡下仙骨腟固定術とロボット支援下仙骨腟固定術における比較検討

  小谷泰史; 村上幸祐; 加嶋洋子; 太田真見子; 宮川知保; 葉 宜慧; 高矢寿光; 中井英勝; 松村謙臣

  第11回日本婦人科ロボット手術学会  2023/01
• 当科におけるロボット支援下仙骨腟固定術と腹腔鏡下仙骨腟固定術との比較検討

  小谷泰史; 村上幸祐; 加嶋洋子; 太田真見子; 宮川知保; 葉 宜慧; 高矢寿光; 中井英勝; 松村謙臣

  第35回日本内視鏡外科学会  2022/12
• 子宮頸部筋腫や広間膜内筋腫に対する腹腔鏡下子宮筋腫核出術  [Invited]

  小谷泰史; 村上幸祐; 藤島理沙; 中井英勝; 松村謙臣

  第62回日本産科婦人科内視鏡学会学術講演会  2022/09
• 子宮腺筋症切除術における腹腔鏡手術と開腹手術との比較検討

  小谷泰史; 森内 芳; 山本貴子; 村上幸祐; 高矢寿光; 中井英勝; 松村謙臣

  第32回近畿エンドメトリオーシス研究会  2022/08
• 安全に行う内視鏡下仙骨腟固定術（LSCからRSCへ）～合併症を経験して、より安全な術式を～  [Invited]

  小谷泰史

  第21回近畿産婦人科内視鏡手術研究会  2022/02
• ロボット支援下仙骨腟固定術の導入と腹腔鏡下仙骨腟固定術との比較検討

  小谷泰史; 村上幸祐; 宮川知保; 青木稚人; 葉 宜慧; 高矢寿光; 中井英勝; 松村謙臣

  第10回日本婦人科ロボット手術学会  2022/01
• 深部子宮内膜症に対する腹腔鏡下手術の当科での実施  [Invited]

  小谷泰史; 村上幸祐; 宮川知保; 貫戸明子; 高矢寿光; 中井英勝; 飛梅孝子; 松村謙臣

  第34回日本内視鏡外科学会  2021/12
• 若手医師に対する腹腔鏡下子宮悪性腫瘍手術の教育の実践

  小谷泰史; 村上幸祐; 葉 宜慧; 貫戸明子; 高矢寿光; 中井英勝; 松村謙臣

  第61回日本産科婦人科内視鏡学会学術講演会  2021/09
• 改めて学ぶ、エキスパートの腹腔鏡下子宮全摘術 ～安全な視野の確保～  [Invited]

  小谷泰史

  第61回日本産科婦人科内視鏡学会学術講演会  2021/09
• Comparison of surgical results between laparoscopic surgery and open surgery in adenomyomectomy

  Yasushi Kotani; Kosuke Murakami; Naho Sasai; Yoko Kashima; Hanako Sato; Mamiko Ohta; Kaori Moriuchi; Kiko Yamamoto; Chiho Miyagawa; Masato Aoki; Yoshie Yo; Akiko Kanto; Hisamitsu Takaya; Kaoru Kawasaki; Hidekatsu Nakai; Noriomi Matsumura

  21th Annual Congress of the Asia Pacific Association for Gynecological Endoscopy  2021/09
• 腹腔鏡下子宮筋腫核出術における腹腔鏡用超音波検査を用いた再発予防の工夫と検討

  小谷泰史; 村上幸祐; 笹井奈穂; 佐藤華子; 加嶋洋子; 太田真見子; 山本貴子; 森内 芳; 宮川知保; 青木稚人; 葉 宜慧; 貫戸明子; 高矢寿光; 川崎 薫; 中井英勝; 松村謙臣

  第61回日本産科婦人科内視鏡学会学術講演会  2021/09
• 子宮体がんにおけるロボット支援下骨盤リンパ節郭清について～ロボット手術の経験から見えてきたこと～

  小谷泰史; 松村謙臣

  第14回関西腹腔鏡下婦人科悪性腫瘍会議  2021/07
• 子宮頸がんに対する広汎子宮全摘術における手術成績の比較検討

  小谷泰史; 村上幸祐; 高矢寿光; 中井英勝; 松村謙臣

  第63回日本婦人科腫瘍学会  2021/07
• 腹腔鏡下子宮全摘術における術式の比較検討（TLH vs. LAVH）

  小谷泰史; 村上幸祐; 城 玲央奈; 山本貴子; 宮川知保; 青木稚人; 八幡 環; 葉 宜慧; 貫戸明子; 高矢寿光; 中井英勝; 松村謙臣

  第73回日本産科婦人科学会  2021/04
• Comparison between Total Laparoscopic Hysterectomy and Laparoscopically-assisted Vaginal Hysterectomy

  Yasushi Kotani; Kosuke Murakami; Mamiko Ota; Kiko Yamamoto; Risa Fujishima; Chiho Miyagawa; Masato Aoki; Tamaki Yahata; Yoshie Yo; Akiko Kanto; Hisamitsu Takaya; Hidekatsu Nakai; Noriomi Matsumura

  第33回 日本内視鏡外科学会  2021/03
• 子宮体がん1A期に対するロボット支援下手術での腹腔鏡下手術との比較検討

  小谷泰史; 太田真見子; 山本貴子; 藤島理沙; 宮川知保; 青木稚人; 八幡 環; 葉 宜慧; 村上幸祐; 貫戸明子; 高矢寿光; 中井英勝; 松村謙臣

  第62回日本婦人科腫瘍学会  2021/01
• 安全に行う腹腔鏡下仙骨腟固定術～術前に仙骨前の血管走行を知って、出血を避ける～

  小谷泰史; 村上幸祐; 佐藤華子; 太田真見子; 城 玲央奈; 山本貴子; 宮川知保; 青木稚人; 八幡 環; 葉 宜慧; 貫戸明子; 高矢寿光; 中井英勝; 松村謙臣

  第60回日本産科婦人科内視鏡学会  2020/12
• ロボット支援下手術の教育方法若手医師への適応と限界  [Invited]

  小谷泰史; 村上幸祐; 笹井奈穂; 太田真見子; 城 玲央奈; 山本貴子; 宮川知保; 青木稚人; 八幡 環; 葉 宜慧; 貫戸明子; 高矢寿光; 中井英勝; 松村謙臣

  第60回日本産科婦人科内視鏡学会学術講演会  2020/12
• 安全に行う腹腔鏡下仙骨腟固定術 術前に仙骨前の血管走行を知って、出血を避ける

  小谷 泰史; 村上 幸祐; 太田 真実子; 城 玲央奈; 山本 貴子; 宮川 知保; 青木 稚人; 八幡 環; 葉 宜慧; 貫戸 明子; 高矢 寿光; 中井 英勝; 松村 謙臣

  日本産科婦人科内視鏡学会雑誌  2020/11  (一社)日本産科婦人科内視鏡学会
  
• 腹腔鏡下広汎子宮全摘術での膀胱子宮靭帯の安全に行う手術操作と病理学的検討

  小谷泰史; 村上幸祐; 佐藤華子; 太田真見子; 城 玲央奈; 山本貴子; 宮川知保; 青木稚人; 八幡 環; 葉 宜慧; 貫戸明子; 高矢寿光; 中井英勝; 松村謙臣

  第43回日本産婦人科手術学会  2020/11
• 腹腔鏡下子宮腺筋症切除術における手術成績と術後成績の開腹手術との比較検討

  小谷泰史; 宮川知保; 太田真実子; 城 玲央奈; 山本貴子; 藤島理沙; 青木稚人; 八幡 環; 葉 宜慧; 村上幸祐; 貫戸明子; 高矢寿光; 中井英勝; 松村謙臣

  第2回 子宮腺筋症の妊孕性温存を考える会  2020/02
• 大学病院において、若手医師や医学部生に教える内視鏡下手術

  小谷泰史; 太田真見子; 山本貴子; 藤島理沙; 宮川知保; 青木稚人; 八幡 環; 葉 宜慧; 村上幸祐; 貫戸明子; 高矢寿光; 中井英勝; 鈴木彩子; 松村謙臣

  第42回日本産婦人科手術学会、第8回日本婦人科ロボット手術学会  2020/02
• 子宮腺筋症に対する子宮全摘術についての術式別にみた比較検討

  小谷泰史; 宮川知保; 山本貴子; 城 玲央奈; 藤島理沙; 青木稚人; 八幡 環; 葉 宜慧; 村上幸祐; 貫戸明子; 高矢寿光; 中井英勝; 鈴木彩子; 松村謙臣

  第41回日本エンドメトリオーシス学会  2020/01
• 子宮腺筋症切除術における腹腔鏡下手術と開腹手術の術後妊娠率と再手術率での比較検討

  小谷泰史; 太田真見子; 山本貴子; 藤島理沙; 宮川知保; 青木稚人; 八幡 環; 葉 宜慧; 村上幸祐; 貫戸明子; 高矢寿光; 中井英勝; 鈴木彩子; 松村謙臣

  第32回 日本内視鏡外科学会  2019/12
• 骨盤臓器脱に対する腹腔鏡下仙骨腟固定術の手術成績とその他の術式との比較検討

  小谷泰史、村上幸祐、山本貴子、藤島理沙、宮川知保、青木稚人、八幡 環、葉 宜慧、貫戸明子、高矢寿光、中井英勝、鈴木彩子、松村謙臣

  第32回 日本内視鏡外科学会  2019/12
• 腹腔鏡下子宮全摘術～技術認定医取得に向けて～  [Invited]

  小谷 泰史

  第3回近畿産婦人科ビデオクリニックセミナー  2019/11
• 長期間GnRHa療法を使用している重症子宮内膜症の2症例での骨密度について

  小谷泰史; 甲斐 冴; 城 玲央奈; 藤島理沙; 青木稚人; 葉 宜慧; 八幡 環; 村上幸祐; 貫戸明子; 高矢寿光; 中井英勝; 鈴木彩子; 松村謙臣

  第21回日本骨粗鬆症学会  2019/10
• Anatomy and surgical procedures performed safely of the vesicouterine ligament in laparoscopic radical hysterectomy  [Invited]

  Kotani Yasushi

  The 6th Biennial Meeting of Asian Society of Gynecologic Oncology, Korea  2019/10
• 腹腔鏡下子宮全摘術の基本手技  [Invited]

  小谷泰史

  熊本婦人科悪性ラパロセミナー  2019/10
• 術前画像検査を用いた仮想現実・拡張現実・複合現実を活用した内視鏡下子宮悪性腫瘍手術の有用性の検討

  小谷泰史; 村上幸祐; 藤島理沙; 青木稚人; 八幡 環; 高矢寿光; 中井英勝; 鈴木彩子; 松村謙臣; 杉本真樹

  第59回日本産科婦人科内視鏡学会  2019/09
• 腹腔鏡下子宮腺筋症切除術における手術成績と再手術率の開腹手術との比較検討  [Not invited]

  小谷泰史; 藤島理沙; 城 玲央奈; 山本貴子; 宮川知保; 青木稚人; 八幡 環; 葉 宜慧; 村上幸祐; 貫戸明子; 高矢寿光; 中井英勝; 鈴木彩子

  第59回日本産科婦人科内視鏡学会  2019/09
• 腹腔鏡下仙骨腟固定術を安全に行うための造影CTを用いた前縦靭帯の付近の血管走行についての検討

  小谷泰史; 村上幸祐; 城; 玲央奈; 甲斐 冴; 藤島理沙; 大須賀拓真; 青木稚人; 葉 宜慧; 高矢寿光; 中井英勝; 鈴木彩子; 松村謙臣

  第21回日本女性骨盤底医学会  2019/07
• ランダム化比較試験におけるバーチャルリアリティシミュレーターを用いた医学教育実習の有用性の検討

  小谷泰史; 藤島理沙; 城 玲央奈; 青木稚人; 葉 宜慧; 村上幸祐; 貫戸明子; 高矢寿光; 中井英勝; 鈴木彩子; 松村謙臣

  第51回医学教育学会  2019/07
• バーチャルリアリティシミュレーターを用いた医学教育実習は外科解剖の知識増加に有用か？

  小谷泰史; 藤島理沙; 城 玲央奈; 青木稚人; 葉 宜慧; 村上幸祐; 貫戸明子; 高矢寿光; 中井英勝; 鈴木彩子; 松村謙臣

  6th Surgical Educational Summit  2019/07
• 腹腔鏡下広汎子宮全摘術における膀胱子宮靱帯の安全に行う手術操作とその解剖

  小谷泰史; 佐藤華子; 大須賀拓真; 藤島理沙; 青木稚人; 葉 宜慧; 村上幸祐; 貫戸明子; 高矢寿光; 中井英勝; 鈴木彩子; 松村謙臣

  第71回日本産科婦人科学会  2019/04
• Management for complications  [Invited]

  Kotani Yasushi

  Minimally Invasive Gynecologic Surgery Workshop in Myanmar 2nd series, Myanmar  2019/02
• Basics of laparoscopic in gyn. Oncology  [Invited]

  Kotani Yasushi

  Minimally Invasive Gynecologic Surgery Workshop in Myanmar 2nd series, Myanmar  2019/02
• Laparoscopic pelvic LNetomy  [Invited]

  Kotani Yasushi

  Minimally Invasive Gynecologic Surgery Workshop in Myanmar 2nd series, Myanmar  2019/02
• DaVinci Siサージカルシステムによるポート配置とドッキングの工夫  [Not invited]

  小谷泰史; 鈴木彩子; 村上幸祐; 高矢寿光; 中井英勝; 松村謙臣

  第7回日本婦人科ロボット手術学会  2019/02
• 子宮体がんにおける ロボット支援下骨盤リンパ節郭清について

  小谷泰史; 松村謙臣

  第10回関西腹腔鏡下婦人科悪性腫瘍会議  2019/01
• 婦人科領域におけるロボット支援手術の現状と今後の課題  [Not invited]

  小谷泰史; 鈴木彩子; 佐藤華子; 城 玲央奈; 藤島理沙; 甲斐 冴; 大須賀拓真; 青木稚人; 葉 宜慧; 村上幸祐; 高矢寿光; 中井英勝; 松村謙臣

  第31回 日本内視鏡外科学会  2018/12
• 腹腔鏡下仙骨腟固定術を安全に行うための工夫～造影CTで仙骨前面の血管を明らかにする～

  小谷泰史; 村上幸祐; 佐藤華子; 山本貴子; 城 玲央奈; 藤島理沙; 大須賀拓真; 甲斐 冴; 青木稚人; 葉 宜慧; 高矢寿光; 中井英勝; 鈴木彩子; 辻 勲; 松村謙臣

  第33回日本女性医学学会  2018/11
• Does medical practice training using virtual reality simulator contribute to an increase in anatomical knowledge?  [Not invited]

  Yasushi Kotani; Ayako Suzuki; Hanako Sato; Reona Shiro; Risa Fujishima; Sayaka Kai; Takuma Osuga; Kosuke Murakami; Hisamitsu Takaya; Hidekatsu Nakai; Isao Tsuji; Noriomi Matsumura

  19th Annual Congress of the Asia Pacific Association for Gynecological Endoscopy, Indonesia  2018/11
• 腹腔鏡下傍大動脈リンパ節郭清術

  小谷泰史

  第1回南大阪手術手技研究会  2018/10
• 精度の高い診断と安全に子宮鏡下手術を行うための外来子宮鏡検査

  小谷泰史; 辻 勲; 佐藤華子; 城 玲央奈; 藤島理沙; 甲斐 冴; 大須賀拓真; 青木稚人; 葉 宜慧; 村上幸祐; 高矢寿光; 中井英勝; 鈴木彩子; 松村謙臣

  第139回近畿産科婦人科学会  2018/10
• 腹腔鏡下広汎子宮全摘術における膀胱子宮靭帯処理を安全に行う手術手技の確立～できる限り膀胱を剥離し、安全に血管処理を行う～

  小谷泰史; 鈴木彩子; 佐藤華子; 山本貴子; 城 玲央奈; 藤島理沙大須賀拓真; 甲斐 冴; 青木稚人; 葉 宜慧; 村上幸祐; 貫戸明子; 高矢寿光; 中井英勝; 辻 勲; 松村謙臣

  第58回日本産科婦人科内視鏡学会  2018/08
• 腹腔鏡下広汎子宮全摘術と全腹腔鏡下子宮全摘術との共通点を意識した腹腔鏡下仙骨腟固定術

  小谷泰史; 村上幸祐; 佐藤華子; 山本貴子; 城 玲央奈; 藤島理沙; 大須賀拓真; 甲斐 冴; 青木稚人; 葉 宜慧; 貫戸明子; 高矢寿光; 中井英勝; 鈴木彩子; 辻 勲; 松村謙臣

  第58回日本産科婦人科内視鏡学会  2018/08
• 標準化をめざした腹腔鏡下仙骨腟固定術の導入と若手医師への教育  [Not invited]

  小谷泰史; 村上幸祐; 佐藤華子; 山本貴子; 城 玲央奈; 藤島理沙; 大須賀拓真; 甲斐 冴; 青木稚人; 葉 宜慧; 高矢寿光; 中井英勝; 鈴木彩子; 辻 勲; 松村謙臣

  第20回日本女性骨盤底医学会  2018/07
• ゆとり世代の若手医師に教える腹腔鏡下子宮全摘術  [Not invited]

  小谷泰史; 飛梅孝子; 佐藤華子; 山本貴子; 藤島理沙; 青木稚人; 葉 宜慧; 高松士郎; 村上幸祐; 高矢寿光; 中井英勝; 鈴木彩子; 辻 勲; 松村謙臣

  第43回日本外科系連合学会  2018/06
• バーチャルリアリティシミュレーターを用いた医学教育実習は解剖学的知識の増加に役立つか?

  小谷泰史; 飛梅孝子; 山本貴子; 藤島理沙; 青木稚人; 村上幸祐; 高矢寿光; 貫戸明子; 島岡昌生; 中井英勝; 辻 勲; 松村謙臣

  第70回日本産科婦人科学会  2018/05
• 広汎子宮全摘術を目指したTLH ～縫合からその応用まで～  [Invited]

  小谷泰史

  第1回和歌山婦人科腹腔鏡下手術セミナー  2018/05
• 静脈血栓塞栓症に対する取り組み 産婦人科医の立場から

  小谷泰史

  南大阪血栓症カンファレンス  2018/03
• ロボット支援下手術における導入と合併症に関しての検討

  小谷泰史; 鈴木彩子; 村上幸祐; 高矢寿光; 中井英勝; 飛梅孝子; 万代昌紀; 松村謙臣

  第10回日本ロボット外科学会  2018/02
• 困難例の経験から安全に配慮したLSC～前壁メッシュと後壁V-Loc後腟壁形成術～  [Not invited]

  小谷泰史

  第12回 日本骨盤臓器脱手術学会  2018/02
• 内視鏡下傍大動脈リンパ節郭清の導入と工夫

  小谷泰史; 鈴木彩子; 村上幸祐; 高矢寿光; 中井英勝; 飛梅孝子; 万代昌紀; 松村謙臣

  第6回日本婦人科ロボット手術研究会  2018/01
• 腹腔鏡下子宮腺筋症切除術における術後妊娠率と再手術率 ～開腹手術との比較検討～  [Not invited]

  小谷泰史; 飛梅孝子; 山本貴子; 藤島理沙; 宮川知保; 青木稚人; 葉 宜慧; 高松士郎; 村上幸祐; 高矢寿光; 島岡昌生; 中井英勝; 鈴木彩子; 辻 勲; 松村謙臣

  第39回 日本エンドメトリーシス学会  2018/01
• 腹腔鏡下仙骨腟固定術を安全に行う工夫と若手医師への教育  [Not invited]

  小谷泰史; 村上幸祐; 山本貴子; 藤島理沙; 宮川知保; 青木稚人; 重田 護; 高松士朗; 葉 宜慧; 高矢寿光; 中井英勝; 飛梅孝子; 鈴木彩子; 松村謙臣

  第30回日本内視鏡外科学会  2017/12
• 骨盤臓器脱に対する腹腔鏡下仙骨腟固定術の教育と安全に行う工夫

  小谷泰史

  平成29年大阪産婦人科医会第9ブロック年末勉強会  2017/11
• Recurrence of uterine myoma after myomectomy: laparotomy vs laparoscopic myomectomy  [Not invited]

  Yasushi Kotani; Takako Tobiume; Risa Fujishima; Mamoru Shiget; Kosuke Murakami; Hisamitsu Takaya; Hidekatsu Nakai; Ayako Suzuki; Isao Tsuji; Noriomi Matsumura

  46th AAGL Globaal Congress on Minimally Invasive Gynecologic Surgery, Washington, D.C., USA  2017/11
• 子宮鏡技術認定医として育成を目指した子宮鏡下手術

  小谷泰史; 小池英爾; 山本貴子; 藤島理沙; 宮川知保; 青木稚人; 重田 護; 高松士朗; 葉 宜慧; 村上幸祐; 貫戸明子; 高矢寿光; 島岡昌生; 中井英勝; 飛梅孝子; 鈴木彩子; 辻 勲; 松村謙臣

  第57回日本産科婦人科内視鏡学会  2017/09
• 研修医に教えるステップ式腹腔鏡下子宮全摘術

  小谷泰史; 飛梅孝子; 山本貴子; 藤島理沙; 宮川知保; 青木稚人; 重田 護; 高松士朗; 葉 宜慧; 村上幸祐; 貫戸明子; 高矢寿光; 島岡昌生; 中井英勝; 鈴木彩子; 辻 勲; 松村謙臣

  第57回日本産科婦人科内視鏡学会  2017/09
• Introduction and evaluation of laparoscopic biopsy of sentinel lymph nodes in early-stage uterine corpus carcinoma  [Not invited]

  Yasushi Kotani; Kosuke Murakami; Shiro Takamatsu; Yoshie Yo; Hisamitsu Takaya; Hidekatsu Nakai; Takako Tobiume; Isao Tsuji; Ayako Suzuki; Noriomi Matsumura

  18th Annual Congress of the Asia Pacific Association for Gynecological Endoscopy、Okayama  2017/09
• A study of recurrence rate after myomectomy: open myomectomy vs laparoscopic myomectomy.  [Not invited]

  Yasushi Kotani; Takako Tobiume; Risa Fujishima; Mamoru Shigeta; Kosuke Murakami; Hisamitsu Takaya; Hidekatsu Nakai; Ayako Suzuki; Isao Tsuji; Noriomi Matsumura

  18th Annual Congress of the Asia Pacific Association for Gynecological Endoscopy、Okayama  2017/09
• 医学教育実習における腹腔鏡トレーニングボックスと腹腔鏡シミュレーターを用いた教育の導入と経験

  小谷泰史; 鈴木彩子; 山本貴子; 藤島理沙; 宮川知保; 青木稚人; 重田 護; 葉 宜慧; 村上幸祐; 貫戸明子; 高矢寿光; 島岡昌生; 中井英勝; 飛梅孝子; 辻 勲; 松村謙臣

  第49回医学教育学会  2017/08
• 腹腔鏡下仙骨腟固定術の当科における導入と安全に行う工夫

  小谷泰史; 村上幸祐; 山本貴子; 藤島理沙; 宮川知保; 青木稚人; 重田 護; 高松士郎; 葉 宜慧; 貫戸明子; 高矢寿光; 島岡昌生; 中井英勝; 飛梅孝子; 鈴木彩子; 辻 勲; 松村謙臣

  第19回日本女性骨盤底医学会  2017/07
• 子宮体癌に対するロボット支援下傍大動脈リンパ節郭清における開腹術との比較検討

  小谷泰史; 山本貴子; 藤島理沙; 宮川知保; 青木稚人; 重田 護; 葉 宜慧; 高松士郎; 村上幸祐; 貫戸明子; 高矢寿光; 島岡昌生; 飛梅孝子; 中井英勝; 鈴木彩子; 辻 勲; 万代昌紀

  第59回日本婦人科腫瘍学会  2017/07
• MIGS Session 2 Management for complications  [Invited]

  Kotani Yasushi

  2th Urogynecological and Minimally Invasive Gynecologic Surgery Workshop, Myanmar  2017/07
• MIGS Session 3 Benign Laparoscopic Surgery 2: Cystectomy and Myomectomy  [Invited]

  Kotani Yasushi

  2th Urogynecological and Minimally Invasive Gynecologic Surgery Workshop, Myanmar  2017/07
• MIGS Session 1 Basics of Laparoscopy: How to Prepare?  [Invited]

  Kotani Yasushi

  2th Urogynecological and Minimally Invasive Gynecologic Surgery Workshop, Myanmar  2017/07
• 女性の一生涯と薬物治療～思春期から老年期まで～  [Invited]

  小谷泰史

  第2回羽曳野市薬剤師会学術講演会  2017/06
• 子宮筋腫核出術における術後再手術に関する検討

  小谷泰史; 飛梅孝子; 山本貴子; 重田 護; 葉 宜慧; 村上幸祐; 貫戸明子; 高矢寿光; 島岡昌生; 中井英勝; 辻 勲; 万代昌紀

  第69回日本産科婦人科学会  2017/04
• 当科におけるロボット支援下手術における導入と現状  [Not invited]

  小谷泰史; 鈴木彩子; 山本貴子; 藤島理沙; 宮川知保; 青木稚人; 重田 護; 葉 宜慧; 高松士朗; 村上幸祐; 貫戸明子; 高矢寿光; 島岡昌生; 飛梅孝子; 中井英勝; 辻 勲; 万代昌紀

  第5回日本婦人科ロボット手術研究会  2017/02
• 子宮体癌に対する逆パラレルドッキング法によるロボット支援下傍大動脈リンパ節郭清の検討

  小谷泰史; 鈴木彩子; 高矢寿光; 飛梅孝子; 万代昌紀

  第9回日本ロボット外科学会  2017/01
• 大きな腫瘤形成を来した膀胱および腸管子宮内膜症の1例

  小谷泰史; 飛梅孝子; 山本貴子; 藤島理沙; 宮川知保; 青木稚人; 重田 護; 高松士郎; 葉 宜慧; 村上幸祐; 高矢寿光; 島岡昌生; 中井英勝; 鈴木彩子; 万代昌紀

  第38回 日本エンドメトリオーシス学会  2017/01
• 当科での内視鏡下子宮全摘術における若手医師への教育の現状

  小谷泰史; 飛梅孝子; 山本貴子; 藤島理沙; 宮川知保; 青木稚人; 重田 護; 葉 宜慧; 高松士郎; 村上幸祐; 高矢寿光; 中井英勝; 鈴木彩子; 万代昌紀

  第29回日本内視鏡外科学会  2016/12
• 腹腔鏡下子宮筋腫核出術における術後再発率と再発予防の工夫～腹腔鏡用超音波検査を用いた手法～  [Not invited]

  小谷泰史; 飛梅孝子; 山本貴子; 藤島理沙; 宮川知保; 青木稚人; 重田 護; 葉 宜慧; 高松士郎; 村上幸祐; 高矢寿光; 中井英勝; 鈴木彩子; 万代昌紀

  第29回日本内視鏡外科学会  2016/12
• A study of the recurrence and reoperation rate of uterine myoma after laparoscopic myomectomy and the recurrence prevention  [Not invited]

  Yasushi Kotani; Takako Tobiume; Mamoru Shigeta; Yoshie Yo; Kousuke Muramkami; Hisamitsu Takaya; Masao Shimaoka; Hidekatsu Nakai; Ayako Suzuki; Masaki Mandai

  17th Annual Congress of the Asia Pacific Association for Gynecological Endoscopy、Taiwan  2016/11
• 腹腔鏡下仙骨腟固定術の標準化をめざした当科における工夫～術前造影CTによる血管走行の確認と術中腹腔鏡用超音波を用いる手法～

  小谷泰史; 飛梅孝子; 山本貴子; 藤島理沙; 宮川知保; 青木稚人; 重田 護; 葉 宜慧; 村上幸祐; 高矢寿光; 島岡昌生; 中井英勝; 鈴木彩子; 辻 勲; 万代昌紀

  第56回日本産科婦人科内視鏡学会  2016/09
• 当科における内視鏡下子宮全摘術における若手医師へのステップ式教育と現状  [Not invited]

  小谷泰史; 飛梅孝子; 山本貴子; 藤島理沙; 宮川知保; 青木稚人; 重田 護; 葉 宜慧; 村上幸祐; 高矢寿光; 島岡昌生; 中井英勝; 鈴木彩子; 辻 勲; 万代昌紀

  第56回日本産科婦人科内視鏡学会  2016/09
• 当科における腹腔鏡下子宮悪性腫瘍手術 ～教室員全員を術者として育成する～

  小谷泰史; 中井英勝; 宮川知保; 藤島理沙; 青木稚人; 葉 宜慧; 村上幸祐; 貫戸明子; 高矢寿光; 浮田真沙世; 島岡昌生; 飛梅孝子; 鈴木彩子; 辻 勲; 万代昌紀

  第58回日本婦人科腫瘍学会  2016/07
• 腹腔鏡下子宮筋腫核出術の術後再発までの期間に関与する因子の検討

  小谷泰史; 辻 勲; 中井英勝; 飛梅孝子; 島岡昌生; 高矢寿光; 村上幸祐; 葉 宜慧; 宮川知保; 藤島理沙; 貫戸明子; 万代昌紀

  第68回日本産科婦人科学会  2016/04
• ４Kで実現する、より安全で精緻な婦人科腹腔鏡下手術～良性疾患から悪性疾患まで～腹腔鏡下単純子宮全摘術（TLH）研修医に教えるステップ式腹腔鏡教育～教室員全員を術者（技術認定医）として育成する～  [Invited]

  小谷泰史

  第68回日本産科婦人科学会  2016/04
• 腹腔鏡下子宮筋腫核出術～当科における診断から治療まで～

  小谷泰史

  第16回近畿産婦人科内視鏡手術研究会  2016/02
• 当科におけるロボット支援下広汎子宮全摘術と開腹術での 広汎子宮全摘術の比較検討

  小谷泰史; 飛梅孝子; 高矢寿光; 鈴木彩子; 万代昌紀

  第8回日本ロボット外科学会  2016/01
• 腹腔鏡下子宮筋腫核出術における術後再発、再手術に関する検討

  小谷泰史; 飛梅孝子; 中井英勝; 島岡昌生; 高矢寿光; 村上幸祐; 鈴木彩子; 万代昌紀

  第28回日本内視鏡外科学会  2015/12
• 当科における腹腔鏡下仙骨腟固定術の導入における工夫

  小谷泰史; 飛梅孝子; 辻 勲; 中井英勝; 島岡昌生; 浮田真沙世; 高矢寿光; 村上幸祐; 青木稚人; 藤島理沙; 宮川知保; 鈴木彩子; 万代昌紀

  第38回 日本産婦人科手術学会  2015/11
• Comparison between robotic-assisted radical hysterectomy and abdominal radical hysterectomy  [Not invited]

  Yasushi Kotani; Ayako Suzuki; Tsuji Isao; Takako Tobiume; Masao Shimaoka; Masayo Ukita; Hisamitsu Takaya; Kosuke Murakami; Masato Aoki; Risa Hujishima; Chiho Miyagawa; Masaki Mandai

  The 4th Biennial Meeting of Asian Society of Gynecologic Oncology, Korea  2015/11
• 腹腔鏡下子宮筋腫核出術における自己血輸血の適応に関する検討

  小谷泰史; 飛梅孝子; 辻 勲; 中井英勝; 島岡昌生; 浮田真沙世; 高矢寿光; 村上幸祐; 青木稚人; 藤島理沙; 宮川知保; 鈴木彩子; 万代昌紀

  第55回日本産科婦人科内視鏡学会  2015/09
• 当科におけるロボット支援下広汎子宮全摘術の現状（同時期に行った開腹広汎子宮全摘術と比較検討）  [Not invited]

  小谷泰史; 鈴木彩子; 辻 勲; 飛梅孝子; 中井英勝; 島岡昌生; 浮田真沙世; 高矢寿光; 村上幸祐; 青木稚人; 万代昌紀

  第57回日本婦人科腫瘍学会  2015/08
• バーチャルリアリティシミュレーターを用いた医学教育実習の導入と有用性の検討

  小谷泰史; 鈴木彩子; 藤島理沙; 宮川知保; 青木稚人; 葉 宜慧; 村上幸祐; 高矢寿光; 島岡昌生; 中井英勝; 飛梅孝子; 辻 勲; 万代昌紀

  第48回医学教育学会  2015/07
• 腹腔鏡トレーニングボックスを用いた医学教育実習の導入と経験

  小谷泰史; 鈴木彩子; 辻 勲; 飛梅孝子; 中井英勝; 島岡昌生; 浮田真沙世; 高矢寿光; 村上幸祐; 青木稚人; 万代昌紀

  第47回医学教育学会  2015/07
• 腹腔鏡下子宮筋腫核出術における術者としての手術適応に関する研究

  小谷泰史; 飛梅孝子; 辻 勲; 中井英勝; 島岡昌生; 浮田真沙世; 高矢寿光; 村上幸祐; 青木稚人; 鈴木彩子; 万代昌紀

  第67回日本産科婦人科学会  2015/04
• 子宮体癌に対するロボット支援下傍大動脈リンパ節郭清における逆パラレルドッキング法  [Not invited]

  小谷泰史; 鈴木彩子; 万代昌紀

  第7回日本ロボット外科学会  2015/02
• 卵巣チョコレートのう胞摘出術後の術後再発と再発予防の検討

  小谷泰史

  子宮内膜症ネットフォーラム  2015/01
• Indications of laparoscopic myomectomy  [Not invited]

  Kotani Yasushi

  15th Annual Congress of the Asia Pacific Association for Gynecological Endoscopy、Malaysia  2014/11
• In Uterine cancers, high expression ratio of aromatase to erythropoietin mRNA levels may be pathognomonic  [Not invited]

  Yasushi Kotani; Yoshiko Yasuda; Eiji Koike; Mitsuru Shiota; Koshiro Obata; Masaki Mandai

  15th International Gynecologic Cancer Society, Melbourne  2014/11
• 当科におけるロボット支援手術の導入における工夫

  小谷泰史; 鈴木彩子; 辻 勲; 飛梅孝子; 中井英勝; 小池英爾; 島岡昌生; 浮田真沙世; 高矢寿光; 村上幸祐; 青木稚人; 万代昌紀

  第37回日本産婦人科手術学会  2014/10
• 腹腔鏡下子宮筋腫核出術における手術成績からみた適応と限界  [Not invited]

  小谷泰史; 飛梅孝子; 中井英勝; 小池英爾; 島岡昌生; 高矢寿光; 万代昌紀

  第27回日本内視鏡外科学会  2014/10
• 婦人科腹腔鏡手術後の術後QOLに対する研究

  小谷泰史; 辻 勲; 飛梅孝子; 中井英勝; 小池英爾; 島岡昌生; 浮田真沙世; 高矢寿光; 村上幸祐; 青木稚人; 鈴木彩子; 小畑幸四郎; 万代昌紀

  第54回日本産科婦人科内視鏡学会  2014/09
• 腹腔鏡下付属器腫瘍手術を行い術後に境界悪性及び悪性腫瘍と判明した症例についての検討

  小谷泰史; 飛梅孝子; 中井英勝; 小池英爾; 浮田真沙世; 鈴木彩子; 万代昌紀

  第56回日本婦人科腫瘍学会  2014/07
• 術前卵巣チョコレート嚢胞の診断で腹腔鏡手術を施行し術後に境界悪性と判明した3症例について

  小谷泰史; 万代昌紀

  南大阪エンドメトリオーシス研究会  2014/05
• 卵巣腫瘍における深部静脈血栓症（DVT）のリスクファクターに関する研究

  小谷泰史; 辻 勲; 飛梅孝子; 中井英勝; 小池英爾; 貫戸明子; 鈴木彩子; 万代昌紀

  第66回日本産科婦人科学会  2014/04
• 子宮頸部筋腫や広靭帯内筋腫における腹腔鏡下子宮筋腫核出術及び腹腔鏡下腟式子宮全摘術の対策と工夫

  小谷泰史; 梅本雅彦; 飛梅孝子; 塩田 充; 万代昌紀

  第26回日本内視鏡外科学会  2013/11
• 当院における子宮粘膜下筋腫及び子宮内膜ポリープ摘出術後の妊娠率とその因子に関する検討

  小谷泰史; 辻 勲; 網 和美; 藤浪菜穂子; 万代昌紀

  第58回日本生殖医学会  2013/10
• 良性卵巣腫瘍合併妊娠での腹腔鏡下卵巣腫瘍摘出術における当院での工夫  [Not invited]

  小谷泰史; 梅本雅彦; 飛梅孝子; 塩田 充; 万代昌紀

  第36回日本産婦人科手術学会  2013/09
• 腹腔鏡下子宮筋腫核出術における手術時間からみた出血量低減の工夫  [Not invited]

  小谷泰史; 梅本雅彦; 飛梅孝子; 塩田 充; 万代昌紀

  第53回日本産科婦人科内視鏡学会  2013/09
• 腹腔鏡下子宮筋腫核出術における手術適応に関する研究

  小谷泰史; 梅本雅彦; 飛梅孝子; 小池英爾; 塩田 充

  第65回日本産科婦人科学会  2013/05
• 良性卵巣子宮内膜症性嚢胞の診断で腹腔鏡手術を施行し、術後に境界悪性と判明した症例についての検討

  小谷泰史; 梅本雅彦; 飛梅孝子; 小畑孝四郎; 塩田 充

  第34回 日本エンドメトリオーシス学会  2013/01
• 腹腔鏡下子宮筋腫核出術における手術成績と当科での工夫  [Not invited]

  小谷泰史; 梅本雅彦; 飛梅孝子; 牛嶋北斗; 塩田 充

  第25回日本内視鏡外科学会  2012/12
• 子宮筋腫合併不妊症における腹腔鏡下子宮筋腫核出術後の妊娠予後の検討

  小谷泰史; 梅本雅彦; 辻 勲; 網 和美; 藤浪菜穂子; 塩田 充

  第57回日本生殖医学会  2012/11
• Recurrence of uterine myoma after laparoscopic myomectomy (LM)  [Not invited]

  Yasushi Kotani; Masahiko Umemoto; Takako Tobiume; Mitsuru Shiota

  13th Annual Congress of the Asia Pacific Association for Gynecological Endoscopy、Thailand  2012/11
• 筋腫の大きさ別にみた術前GnRHa療法の有無における腹腔鏡下子宮筋腫核出術の手術成績の検討

  小谷泰史; 梅本雅彦; 飛梅孝子; 宮崎綾子; 牛嶋北斗; 塩田 充

  第52回日本産科婦人科内視鏡学会  2012/09
• 婦人科良性疾患における深部静脈血栓症（DVT）の予防及び治療とリスクファクターに関する検討  [Not invited]

  小谷泰史; 梅本雅彦; 飛梅孝子; 塩田 充; 星合 昊

  第37回日本外科系連合学会  2012/06
• Y-1-2 腹腔鏡下子宮筋腫核出術における術後再発率に関する検討(優秀演題賞候補演題 婦人科腫瘍学,優秀演題賞候補プログラム,第64回日本産科婦人科学会学術講演会)

  小谷 泰史; 梅本 雅彦; 飛梅 孝子; 塩田 充; 星合 昊

  日本産科婦人科學會雜誌  2012  日本産科婦人科学会
  
• 腹腔鏡下子宮筋腫核出術（Laparoscopic Myomectomy：LM）における手術適応と再発率に関する検討

  小谷泰史; 梅本雅彦; 飛梅孝子; 塩田 充; 星合 昊

  第24回日本内視鏡外科学会  2011/12
• Incidence of complications in patients with benign gynecological diseases by BMI and level of complexity of laparoscopic surgery  [Not invited]

  Yasushi Kotani; Mitsuru Shiota; Masahiko Umemoto; Takako Tobiume; Hiroshi Hoshiai

  6th AAGL International Congresson Minimally Invasive Gynecology、12th APAGE Annual Congress、Osaka  2011/12
• 良性婦人科疾患における腹腔鏡手術での手術難易度別にみたBMIと合併症に関する研究

  小谷泰史; 梅本雅彦; 飛梅孝子; 塩田 充; 星合 昊

  第51回日本産科婦人科内視鏡学会  2011/08
• 当院での10歳代における腹腔鏡手術

  小谷泰史; 梅本雅彦; 飛梅孝子; 塩田 充; 星合 昊

  第29回日本思春期学会  2010/06
• 腹腔鏡手術にBMI(body mass index)が及ぼす影響

  小谷泰史; 梅本雅彦; 飛梅孝子; 島岡昌生; 塩田 充; 星合 昊

  第49回日本産科婦人科内視鏡学会  2009/09
• A case of intravenous leiomyomatosis associated with endometrial cancer  [Not invited]

  Yasushi Kotani; Mitsuru Shiota; Masahiko Umemoto; Takako Tobiume; Eiji Koike; Masao Shimaoka; Yoko Takahashi; Hiroshi Hoshiai

  The 20th Asia and Oceanie Congress of Obstetrics and Gynecologicy、Tokyo  2009/09
• 分娩を契機に高アンモニア血症を発症したカルバミルリン酸合成酵素欠損症の1例

  小谷泰史; 梅本雅彦; 飛梅孝子; 釣谷充弘; 島岡昌生; 塩田 充; 星合 昊; 新屋敷康

  第120回近畿産科婦人科学会  2009/06
• 腹腔鏡下子宮筋腫核出術における術後再発率に関する検討

  小谷泰史; 梅本雅彦; 飛梅孝子; 島岡昌生; 塩田 充; 星合 昊

  第34回日本外科系連合会  2009/06
• 子宮筋腫核出術における術後再発率に関する検討

  小谷泰史; 梅本雅彦; 飛梅孝子; 島岡昌生; 塩田 充; 星合 昊

  第61回日本産科婦人科学会  2009/04
• Recurrence rate after laparoscopic myomectomy (LM) with preoperative GnRHa therapy  [Not invited]

  Yasushi Kotani; Masahiko Umemoto; Takako Tobiume; Masao Shimaoka; Mitsuru Shiota; Hiroshi Hoshiai

  18th Annual Congress of international Society for Gynecologic Endoscopy、Thailand  2009/03
• 腹腔鏡下子宮筋腫核出術（LM）の再発率に関する検討

  小谷泰史; 梅本雅彦; 飛梅孝子; 島岡昌生; 塩田 充; 星合 昊

  第119回近畿産科婦人科学会  2008/11
• The comparison between laparotomy myomectomy and laparoscopic myomectomy  [Not invited]

  Yasushi Kotani; Masahiko Umemoto; Isao Tsuji; Takako Tobiume; Masao Shimaoka; Kazumi Kanemura; Mitsuru Shiota; Hiroshi Hoshiai

  9th Annual Congress of the Asia Pacific Association for Gynecological Endoscopy、Korea  2008/10
• 腹腔鏡下子宮筋腫核出術の適応に関する研究

  小谷泰史; 梅本雅彦; 飛梅孝子; 島岡昌生; 塩田 充; 星合 昊

  第21回日本内視鏡外科学会  2008/09
• A study of the significance of preoperative GnRH agonist therapy in laparoscopic myomectomy  [Not invited]

  Yasushi Kotani; Masahiko Umemoto; Takako Tobiume; Masao Shimaoka; Mitsuru Shiota; Hiroshi Hoshiai

  Endoscopic and Laparoscopic Surgeons of Asia 2008、Yokohama  2008/09
• A study on the indication of laparoscopic myomectomy  [Not invited]

  Yasushi Kotani; Masahiko Umemoto; Takako Tobiume; Masao Shimaoka; Mitsuru Shiota; Hiroshi Hoshiai

  11th World Congress of Endoscopic Surgery、Yokohama  2008/09
• 当科における子宮鏡手術の検討

  小谷泰史; 梅本雅彦; 小池英爾; 飛梅孝子; 島岡昌生; 小畑孝四郎; 塩田 充; 星合 昊

  第48回日本産科婦人科内視鏡学会  2008/07
• 腹腔鏡下子宮筋腫核出術（LM）に対する術前GnRHアゴニスト療法の有効性の検討

  小谷泰史; 塩田 充; 梅本雅彦; 飛梅孝子; 島岡昌生; 星合 昊

  第118回近畿産科婦人科学会  2008/06
• A Case of Emergency Caesarean Section as a Result of Acute Eosinophilic Pneumonia during Pregnancy  [Not invited]

  Yasushi Kotani; Kunihiko Doh; Masahiko Umemoto; Hiromi Doi; Hidekatsu Nakai; Takako Tobiume; Hiromitsu Tsuritani; Masao Shimaoka; Mitsuru Shiota; Hiroshi Hoshiai

  15th Congress of the Federation of Asia and Oceania Perinatal Societies、Nagoya  2008/05
• 腹腔鏡下子宮筋腫核出術の手術成績とその評価

  小谷泰史; 梅本雅彦; 辻 勲; 飛梅孝子; 島岡昌生; 金村和美; 塩田 充; 星合 昊

  第60回日本産科婦人科学会  2008/04
• 子宮筋腫合併不妊症に対する腹腔鏡下子宮筋腫核出術の妊娠予後の検討

  小谷泰史; 梅本雅彦; 辻 勲; 飛梅孝子; 島岡昌生; 金村和美; 塩田 充; 星合 昊

  第117回近畿産科婦人科学会  2007/11
• 婦人科腹腔鏡手術でのクリティカルパスについての検討  [Not invited]

  小谷泰史; 塩田 充; 梅本雅彦; 飛梅孝子; 島岡昌生; 星合 昊

  第20回日本内視鏡外科学会  2007/11
• The surgical results and evaluation of laparoscopic myomectomy  [Invited]

  Yasushi Kotani; Masahiko Umemoto; Isao Tsuji; Takako Tobiume; Masao Shimaoka; Kazumi Kanemura; Mitsuru Shiota; Hiroshi Hoshiai

  １1th Bulgarian Congress of Obstetrics and Gynecology,Bulgaria  2007/10
• A case of intravenous leiomyomatosis associated with endometrial cancer  [Not invited]

  Yasushi Kotani; Mitsuru Shiota; Masahiko Umemoto; Takako Tobiume; Eiji Koike; Masao Shimaoka; Yoko Takahashi; Hiroshi Hoshiai

  The 20th Asia and Oceanie Congress of Obstetrics and Gynecologicy、Tokyo、Japan  2007/07
• 腹腔鏡下子宮筋腫核出術に対するGnRHアゴニスト療法の有効性の検討

  小谷泰史; 塩田 充; 梅本雅彦; 飛梅孝子; 島岡昌生; 星合 昊

  第116回近畿産科婦人科学会  2007/06
• 上皮性卵巣癌Ⅰ期症例の予後からみた腹腔鏡下手術の適応に関する検討

  小谷泰史; 塩田 充; 梅本雅彦; 飛梅孝子; 島岡昌生; 星合 昊

  第59回日本産科婦人科学会  2007/04
• Laparoscopic mucin removal of the patients with pseudomyxoma peritonei.  [Not invited]

  Yasushi Kotani; Mitsuru Shiota; Masahiko Umemoto; Takako Tobiume; Masao Shimaoka; Hiroshi Hoshiai

  16th Annual Congress of international Society for Gynecologic Endoscopy  2007/03
• Laparoscopic mucin removal of the patients with pseudomyxoma peritonei  [Not invited]

  Yasushi Kotani; Mitsuru Shiota; Masahiko Umemoto; Takako Tobiume; Masao Shimaoka; Hiroshi Hoshiai

  8th Annual Congress of the Asia Pacific Association for Gynecological Endoscopy, Osaka  2007/03
• 子宮鏡下筋腫摘出術施行時に著明な電解質異常を認めた水中毒の1例

  小谷泰史; 塩田 充; 椎名昌美; 梅本雅彦; 飛梅孝子; 島岡昌生; 星合 昊

  第7回近畿産婦人科内視鏡研究会  2007/02
• 婦人科腹腔鏡手術に対する肥満の関与

  小谷泰史; 塩田 充; 梅本雅彦; 飛梅孝子; 島岡昌生; 星合 昊

  第19回日本内視鏡外科学会  2006/12
• 性分化異常を伴った未分化胚細胞腫の一例

  小谷泰史; 塩田 充; 椎名昌美; 梅本雅彦; 飛梅孝子; 島岡昌生; 星合 昊

  第115回近畿産科婦人科学会  2006/11
• 腹腔鏡下手術を行った腹膜偽粘液腫の４症例

  小谷泰史; 塩田 充; 梅本雅彦; 飛梅孝子; 島岡昌生; 星合 昊

  第29回日本産婦人科手術学会  2006/11
• 腹腔鏡下腟式子宮全摘術の手術成績におけるBMI(body mass index)の関与

  小谷泰史; 塩田 充; 梅本雅彦; 飛梅孝子; 島岡昌生; 星合 昊

  第46回日本産科婦人科内視鏡学会  2006/08
• 子宮体癌を合併した静脈内平滑筋腫の1例

  小谷泰史; 塩田 充; 梅本雅彦; 小池英爾; 島岡昌生; 高橋陽子; 星合 昊

  第58回日本産婦人科学会  2006/04
• 婦人科領域における腹腔鏡下手術に対してBMI(body mass index)が及ぼす影響に関する研究

  小谷泰史; 塩田 充; 梅本雅彦; 飛梅孝子; 島岡昌生; 星合 昊

  第18回日本内視鏡外科学会  2005/12
• 子宮頸部円錐切除術に対する超音波凝固切開装置（SonoSurge）の有用性について

  小谷泰史; 塩田 充; 梅本雅彦; 飛梅孝子; 島岡昌生; 星合 昊

  第28回日本産婦人科手術学会  2005/12
• 腹腔鏡下手術に対してBMI(body mass index)が及ぼす影響に関する研究

  小谷泰史; 塩田 充; 梅本雅彦; 飛梅孝子; 島岡昌生; 星合 昊

  第45回日本産科婦人科内視鏡学会  2005/07
• 腹腔鏡下腟式子宮全摘術における手術成績とBMI(body mass index）との関連

  小谷泰史; 塩田 充; 梅本雅彦; 飛梅孝子; 島岡昌生; 星合 昊

  第57回日本産科婦人科学会  2005/04
• 当科における内視鏡下子宮筋腫核出術に関する検討

  小谷泰史; 塩田 充; 梅本雅彦; 飛梅孝子; 島岡昌生; 星合 昊

  第44回日本産科婦人科内視鏡学会  2004/08
• 腹腔鏡下に粘液除去を反復し20年長期生存していた腹膜偽粘液腫の１例

  小谷泰史; 塩田 充; 梅本雅彦; 上田 晴彦; 島岡昌生; 星合 昊

  第56回日本産科婦人科学会  2004/04
• 腹腔鏡下に粘液除去を反復した腹膜偽粘液腫の１例

  小谷泰史; 塩田 充; 梅本雅彦; 飛梅孝子; 星合 昊

  第16回日本内視鏡外科学会  2003/12
• 腹腔鏡下に粘液除去を反復した腹膜偽粘液腫の１例

  小谷泰史; 塩田 充; 上田 晴彦; 星合 昊

  第53回近大医学会学術講演会  2003/07
• 腹腔鏡下に粘液除去を反復した腹膜偽粘液腫の１例  [Not invited]

  小谷泰史; 塩田 充; 上田晴彦; 星合 昊

  第43回日本産科婦人科内視鏡学会  2003/07

MISC

• どうする？子宮腺筋症の管理 子宮腺筋症に対する治療～手術療法1～

  小谷泰史; 松村謙臣  産婦人科の実際  2022/11  [Invited]
  
• AYA世代の女性ヘルスケア－対応と実際－ 子宮筋腫への対応

  小谷泰史; 松村謙臣  産婦人科の実際  71-  1122  -1126  2022/09  [Invited]
  
• 【異所性妊娠の最新診療】異所性妊娠の手術療法

  小谷 泰史; 藤島 理沙; 松村 謙臣  産科と婦人科  87-  (7)  783  -787  2020/07  [Invited]
  
• 臨床実習での腹腔鏡トレーニングボックス実習と賞罰の効果

  藤島 理沙; 小谷 泰史; 城 玲央奈; 甲斐 冴; 青木 稚人; 葉 宜慧; 村上 幸祐; 高矢 寿充; 中井 英勝; 鈴木 彩子  医学教育  50-  (Suppl.)  129  -129  2019/07
• ランダム化比較試験におけるバーチャルリアリティシミュレーターを用いた医学教育実習の有用性の検討

  小谷 泰史; 藤島 理沙; 城 玲央奈; 青木 稚人; 葉 宜慧; 村上 幸祐; 貫戸 明子; 高矢 寿光; 中井 英勝; 鈴木 彩子; 松村 謙臣  医学教育  50-  (Suppl.)  170  -170  2019/07
• SPIO-MRIと鉄染色は、子宮頸癌・体癌のセンチネルリンパ節同定およびリンパ節転移診断に有用である

  村上 幸祐; 鈴木 彩子; 佐藤 華子; 城 玲央奈; 大須賀 拓真; 甲斐 冴; 藤島 理沙; 青木 稚人; 葉 宜慧; 貫戸 明子; 高矢 寿光; 小谷 泰史; 中井 英勝; 辻 勲; 松村 謙臣  日本婦人科腫瘍学会雑誌  37-  (3)  457  -457  2019/06
• 明細胞癌に合併し未熟奇形種から発生した横紋筋肉腫の一例

  青木 稚人; 村上 幸祐; 中井 英勝; 大須賀 拓真; 葉 宜慧; 貫戸 明子; 高矢 寿光; 小谷 泰史; 鈴木 彩子; 辻 勲; 松村 謙臣  日本婦人科腫瘍学会雑誌  37-  (3)  568  -568  2019/06
• 子宮筋腫と肉腫の鑑別に有用なMRI画像所見の設定とその解析

  鈴木彩子; 城玲央奈; 藤島理沙; 甲斐冴; 大須賀拓真; 青木稚人; 佐藤華子; 貫戸明子; 高矢寿光; 小谷泰史; 辻勲; 松村謙臣  日本産科婦人科学会雑誌  71-  (臨増)  S.444  -444  2019/02
• チョコレート嚢胞合併不妊に対する手術の意義

  辻勲; 藤島理沙; 佐藤華子; 城玲央奈; 甲斐冴; 青木稚人; 葉宜慧; 村上幸祐; 貫戸明子; 小谷泰史; 鈴木彩子; 松村謙臣  日本産科婦人科学会雑誌  71-  (臨増)  S.405  -405  2019/02
• 腹腔鏡下広汎子宮全摘術における膀胱子宮靱帯の安全に行う手術操作とその解剖

  小谷 泰史; 佐藤 華子; 大須賀 拓真; 藤島 理沙; 青木 稚人; 葉 宜慧; 村上 幸祐; 貫戸 明子; 高矢 寿光; 中井 英勝; 鈴木 彩子; 松村 謙臣  日本産科婦人科学会雑誌  71-  (臨増)  S  -355  2019/02
• 【外科解剖学から解き明かす広汎子宮全摘出術】子宮周囲の解剖と広汎子宮全摘出術の工夫(3)

  小谷 泰史; 松村 謙臣  産婦人科の実際  67-  (13)  1753  -1758  2018/12
• 【外科解剖学から解き明かす広汎子宮全摘出術】 子宮周囲の解剖と広汎子宮全摘出術の工夫(3)

  小谷 泰史; 松村 謙臣  産婦人科の実際  67-  (13)  1753  -1758  2018/12  [Invited]
  
• 腹腔鏡下仙骨腟固定術を安全に行うための工夫 造影CTで仙骨前面の血管を明らかにする

  小谷 泰史; 村上 幸祐; 佐藤 華子; 山本 貴子; 城 玲央奈; 藤島 理沙; 大須賀 拓真; 甲斐 冴; 青木 稚人; 葉 宜慧; 高矢 寿光; 中井 英勝; 鈴木 彩子; 辻 勲; 松村 謙臣  日本女性医学学会雑誌  26-  (Suppl.)  180  -180  2018/10
• 未成年における腹腔鏡下手術の現状とその特徴について

  甲斐 冴; 小谷 泰史; 佐藤 華子; 山本 貴子; 城 玲央奈; 藤島 理沙; 大須賀 拓真; 青木 稚人; 葉 宜慧; 村上 幸祐; 高矢 寿光; 中井 英勝; 鈴木 彩子; 辻 勲; 松村 謙臣  日本女性医学学会雑誌  26-  (Suppl.)  190  -190  2018/10
• 腹腔鏡下広汎子宮全摘出術の現状の問題点と今後の課題

  小谷泰史  産婦人科の進歩  70-  365  -368  2018/10  [Invited]
  
• 精度の高い診断と安全に子宮鏡下手術を行うための外来子宮鏡検査

  小谷 泰史; 辻 勲; 佐藤 華子; 城 玲央奈; 藤島 理沙; 甲斐 冴; 大須賀 拓真; 青木 稚人; 葉 宜慧; 村上 幸祐; 高矢 寿光; 中井 英勝; 鈴木 彩子; 松村 謙臣  産婦人科の進歩  70-  (4)  477  -477  2018/09
• 腹腔鏡下広汎子宮全摘術と全腹腔鏡下子宮全摘術との共通点を意識した腹腔鏡下仙骨腟固定術

  小谷泰史; 村上幸祐; 佐藤華子; 山本貴子; 城玲央奈; 藤島理沙; 大須賀拓真; 甲斐冴; 青木稚人; 葉宜慧; 貫戸明子; 高矢寿光; 中井英勝; 鈴木彩子; 辻勲; 松村謙臣  日本産科婦人科内視鏡学会雑誌  34-  (Supplement 1)  353  -353  2018/08
• 遺伝性乳癌卵巣癌症候群に対するリスク低減卵巣卵管切除術を施行した3例

  甲斐冴; 小谷泰史; 佐藤華子; 山本貴子; 城玲央奈; 藤島理沙; 大須賀拓真; 青木稚人; 葉宜慧; 村上幸祐; 貫戸明子; 高矢寿光; 中井英勝; 鈴木彩子; 辻勲; 松村謙臣  日本産科婦人科内視鏡学会雑誌  34-  (Supplement 1)  357  -357  2018/08
• 腹腔鏡下広汎子宮全摘術における膀胱子宮靱帯処理を安全に行う手術手技の確立 できる限り膀胱を剥離し、安全に血管の処理を行う

  小谷 泰史; 鈴木 彩子; 佐藤 華子; 山本 貴子; 城 玲央奈; 藤島 理沙; 大須賀 拓真; 甲斐 冴; 青木 稚人; 葉 宜慧; 村上 幸祐; 貫戸 明子; 高矢 寿光; 辻 勲; 中井 英勝; 松村 謙臣  日本産科婦人科内視鏡学会雑誌  34-  (Suppl.I)  371  -371  2018/08
• 当施設における腹腔鏡下傍大動脈リンパ節郭清術の手術成績と合併症の検討

  大須賀拓真; 小谷泰史; 佐藤華子; 城玲央奈; 山本貴子; 藤島理沙; 甲斐冴; 青木稚人; 葉宜慧; 村上幸祐; 貫戸明子; 高矢寿光; 中井英勝; 鈴木彩子; 辻勲; 松村謙臣  日本産科婦人科内視鏡学会雑誌  34-  (Supplement 1)  307  -307  2018/08
• 腹腔鏡下仙骨腟固定術と従来式手術での手術成績と術後再発率の比較検討

  貫戸明子; 小谷泰史; 佐藤華子; 山本貴子; 城玲央奈; 藤島理沙; 大須賀拓真; 甲斐冴; 青木稚人; 葉宜慧; 村上幸祐; 高矢寿光; 中井英勝; 鈴木彩子; 辻勲; 松村謙臣  日本産科婦人科内視鏡学会雑誌  34-  (Supplement 1)  353  -353  2018/08
• 子宮腺筋症の妊孕性温存手術 腹腔鏡下子宮腺筋症切除術における術後妊娠率と再手術率 開腹手術との比較検討

  小谷 泰史; 飛梅 孝子; 山本 貴子; 藤島 理沙; 宮川 知保; 青木 稚人; 葉 宜慧; 高松 士朗; 村上 幸祐; 高矢 寿光; 島岡 昌生; 中井 英勝; 鈴木 彩子; 辻 勲; 松村 謙臣  日本エンドメトリオーシス学会会誌  39-  105  -108  2018/07
• 子宮腺筋症の妊孕性温存手術 腹腔鏡下子宮腺筋症切除術における術後妊娠率と再手術率 開腹手術との比較検討

  小谷 泰史; 飛梅 孝子; 山本 貴子; 藤島 理沙; 宮川 知保; 青木 稚人; 葉 宜慧; 高松 士朗; 村上 幸祐; 高矢 寿光; 島岡 昌生; 中井 英勝; 鈴木 彩子; 辻 勲; 松村 謙臣  日本エンドメトリオーシス学会会誌  39-  105  -108  2018/07  [Refereed]
  
• SPIOを用いた新しいリンパ節転移診断法

  村上 幸祐; 鈴木 彩子; 佐藤 華子; 山本 貴子; 藤島 理沙; 青木 稚人; 高松 士朗; 葉 宜慧; 貫戸 明子; 高矢 寿光; 小谷 泰史; 飛梅 孝子; 中井 英勝; 辻 勲; 松村 謙臣  産婦人科の進歩  70-  (2)  221  -221  2018/05
• 【産科・婦人科の手術看護パーフェクトマニュアル】(第2章)実践編 術式別の術中看護マニュアル 異所性妊娠手術

  小谷 泰史  オペナーシング  (2018臨時増刊)  99  -105  2018/05  [Invited]
  
• ジエノゲスト長期投与継続の工夫

  飛梅 孝子; 小谷 泰史; 青木 稚人; 葉 宜慧; 村上 幸祐; 高矢 寿光; 貫戸 明子; 島岡 昌生; 中井 英勝; 辻 勲; 鈴木 彩子; 松村 謙臣  日本産科婦人科学会雑誌  70-  (2)  741  -741  2018/02
• 子宮筋腫核出術術後妊娠における周産期予後に関する解析 腹腔鏡手術と開腹手術との比較

  藤島 理沙; 小谷 泰史; 山本 貴子; 青木 稚人; 葉 宜慧; 村上 幸祐; 高矢 寿光; 貫戸 明子; 島岡 昌生; 中井 英勝; 辻 勲; 松村 謙臣  日本産科婦人科学会雑誌  70-  (2)  835  -835  2018/02
• チョコレート嚢胞合併不妊の手術適応に関する検討

  辻 勲; 藤島 理沙; 山本 貴子; 青木 稚人; 村上 幸祐; 貫戸 明子; 小谷 泰史; 島岡 昌生; 中井 英勝; 飛梅 孝子; 鈴木 彩子; 松村 謙臣  日本産科婦人科学会雑誌  70-  (2)  917  -917  2018/02
• バーチャルリアリティシミュレーターを用いた医学教育実習は解剖学的知識の増加に役立つか?

  小谷 泰史; 飛梅 孝子; 山本 貴子; 藤島 理沙; 青木 稚人; 村上 幸祐; 高矢 寿光; 貫戸 明子; 島岡 昌生; 中井 英勝; 辻 勲; 松村 謙臣  日本産科婦人科学会雑誌  70-  (2)  922  -922  2018/02
• 鼠径ヘルニアを合併した卵巣茎捻転を繰り返す症例に腹腔鏡下で卵巣固定と鼠径ヘルニア縫合を行った1例

  青木 稚人; 小谷 泰史; 山本 貴子; 高松 士朗; 葉 宜慧; 村上 幸祐; 高矢 寿光; 中井 英勝; 飛梅 孝子; 鈴木 彩子  日本内視鏡外科学会雑誌  22-  (7)  EP016  -07  2017/12
• 子宮内膜癌に対する腹腔鏡下子宮悪性腫瘍手術 当院での取り組み・成績・応用

  飛梅 孝子; 小谷 泰史; 中井 英勝; 葉 宜慧; 村上 幸祐; 高矢 寿光; 鈴木 彩子  日本内視鏡外科学会雑誌  22-  (7)  EP035  -03  2017/12
• 骨盤臓器脱に対する腹腔鏡下仙骨腟固定術

  小谷 泰史  産婦人科の進歩  69-  393  -398  2017/10  [Refereed][Invited]
  
• 研修医に教えるステップ式腹腔鏡下子宮全摘術

  小谷 泰史; 飛梅 孝子; 山本 貴子; 藤島 理沙; 宮川 知保; 青木 稚人; 重田 護; 高松 士朗; 葉 宜慧; 村上 幸祐; 貫戸 明子; 高矢 寿光; 島岡 昌生; 中井 英勝; 鈴木 彩子; 辻 勲; 松村 謙臣  日本産科婦人科内視鏡学会雑誌  33-  (Suppl.I)  424  -424  2017/08
• 子宮鏡技術認定医として育成を目指した子宮鏡下手術

  小谷 泰史; 小池 英爾; 山本 貴子; 藤島 理沙; 宮川 知保; 青木 稚人; 重田 護; 高松 士朗; 葉 宜慧; 村上 幸祐; 貫戸 明子; 高矢 寿光; 島岡 昌生; 中井 英勝; 飛梅 孝子; 鈴木 彩子; 辻 勲; 松村 謙臣  日本産科婦人科内視鏡学会雑誌  33-  (Suppl.I)  494  -494  2017/08
• 誰もが安全にできるLSCをめざして

  村上 幸祐; 小谷 泰史; 山本 貴子; 藤島 理沙; 宮川 知保; 重田 護; 高松 士朗; 葉 宜慧; 貫戸 明子; 高矢 寿光; 島岡 昌生; 飛梅 孝子; 中井 英勝; 鈴木 彩子; 松村 謙臣  日本産科婦人科内視鏡学会雑誌  33-  (Suppl.I)  336  -336  2017/08
• 困難症例に対する腹腔鏡下子宮全摘術 子宮内膜症、頸部筋腫、巨大子宮の当科での対応

  高矢 寿光; 小谷 泰史; 山本 貴子; 藤島 理沙; 宮川 知保; 青木 稚人; 重田 護; 高松 士朗; 葉 宜慧; 村上 幸祐; 貫戸 明子; 島岡 昌生; 中井 英勝; 飛梅 孝子; 鈴木 彩子; 辻 勲; 松村 謙臣  日本産科婦人科内視鏡学会雑誌  33-  (Suppl.I)  860  -860  2017/08
• 腹腔鏡下子宮筋腫核出術における腹腔鏡超音波検査の有効性の検討

  重田 護; 小谷 泰史; 山本 貴子; 藤島 理沙; 宮川 知保; 青木 稚人; 高松 士朗; 葉 宜慧; 村上 幸祐; 貫戸 明子; 高矢 寿光; 島岡 昌生; 中井 英勝; 飛梅 孝子; 鈴木 彩子; 辻 勲; 松村 謙臣  日本産科婦人科内視鏡学会雑誌  33-  (Suppl.I)  1114  -1114  2017/08
• 子宮内膜癌に対する腹腔鏡下子宮悪性腫瘍手術 当院での取り組み・成績・応用

  飛梅 孝子; 小谷 泰史; 高松 志朗; 葉 宜慧; 村上 幸祐; 高矢 寿光; 中井 英勝; 鈴木 彩子; 松村 謙臣; 万代 昌紀  日本産科婦人科内視鏡学会雑誌  33-  (Suppl.I)  351  -351  2017/08
• SPIO造影MRIを用いた新しい骨盤内リンパ節転移診断

  村上 幸祐; 鈴木 彩子; 山本 貴子; 藤島 理沙; 宮川 知保; 重田 護; 高松 士朗; 葉 宜慧; 貫戸 明子; 高矢 寿光; 小谷 泰史; 島岡 昌生; 飛梅 孝子; 中井 英勝; 辻 勲; 万代 昌紀  日本婦人科腫瘍学会雑誌  35-  (3)  560  -560  2017/06
• 子宮体癌に対するロボット支援下傍大動脈リンパ節郭清における開腹術との比較検討

  小谷 泰史; 山本 貴子; 藤島 理沙; 宮川 知保; 青木 稚人; 重田 護; 葉 宜慧; 高松 士朗; 村上 幸祐; 貫戸 明子; 高矢 寿光; 島岡 昌生; 飛梅 孝子; 中井 英勝; 辻 勲; 鈴木 彩子; 万代 昌紀  日本婦人科腫瘍学会雑誌  35-  (3)  621  -621  2017/06
• 子宮頸部・子宮内膜・卵巣に異なる組織型の浸潤癌を同時に認めた3重複癌の1例

  高松 士朗; 重田 護; 村上 幸祐; 高矢 寿光; 小谷 泰史; 飛梅 孝子; 中井 英勝; 辻 勲; 鈴木 彩子; 万代 昌紀  日本婦人科腫瘍学会雑誌  35-  (3)  679  -679  2017/06
• SPIO造影MRIを用いた新しい骨盤内リンパ節転移診断

  村上 幸祐; 鈴木 彩子; 山本 貴子; 重田 護; 高松 士朗; 葉 宜慧; 貫戸 明子; 高矢 寿光; 小谷 泰史; 中井 英勝; 辻 勲; 万代 昌紀  日本産科婦人科学会雑誌  69-  (2)  707  -707  2017/02
• ジエノゲスト継続治療困難症例の検討

  飛梅 孝子; 小谷 泰史; 宮川 知保; 藤島 理沙; 高松 士朗; 葉 宜慧; 村上 幸祐; 島岡 昌生; 中井 英勝; 鈴木 彩子; 辻 勲; 万代 昌紀  日本産科婦人科学会雑誌  69-  (2)  944  -944  2017/02
• 子宮筋腫核出術における術後再手術に関する検討

  小谷 泰史; 飛梅 孝子; 山本 貴子; 重田 護; 葉 宜慧; 村上 幸祐; 貫戸 明子; 高矢 寿光; 島岡 昌生; 中井 英勝; 辻 勲; 万代 昌紀  日本産科婦人科学会雑誌  69-  (2)  946  -946  2017/02
• 婦人科手術における3D-CT画像を用いた術前シミュレーションの有用性

  鈴木 彩子; 村上 幸祐; 小谷 泰史; 藤島 理沙; 宮川 知保; 高松 士朗; 高矢 寿光; 貫戸 明子; 島岡 昌生; 飛梅 孝子; 中井 英勝; 万代 昌紀  日本産科婦人科学会雑誌  69-  (2)  950  -950  2017/02
• 【ここが知りたい 産婦人科周術期管理】腫瘍領域 子宮体癌に対する腹腔鏡手術

  万代 昌紀; 小谷 泰史; 中井 英勝; 鈴木 彩子  産科と婦人科  84-  (2)  158  -163  2017/02  [Invited]
  
• 当科における再発卵巣癌に対するベバシズマブの使用経験

  村上幸祐; 中井英勝; 藤島理沙; 宮川知保; 青木稚人; 葉 宜慧; 貫戸明子; 高矢寿光; 浮田真沙世; 小谷泰史; 島岡昌生; 飛梅孝子; 辻 勲; 鈴木彩子; 万代昌紀  産婦人科の進歩  68-  290  -293  2016/08
• 当院における高齢出産に関する検討

  藤島理沙; 島岡昌生; 宮川知保; 青木稚人; 葉 宜慧; 村上幸祐; 貫戸明子; 高矢寿光; 浮田真沙世; 小谷泰史; 飛梅孝子; 中井英勝; 辻 勲; 鈴木彩子; 万代昌紀  産婦人科の進歩  68-  322  -324  2016/08
• 当科における腹腔鏡下子宮体癌手術の工夫

  浮田 真沙世; 青木 稚人; 葉 宜慧; 村上 幸祐; 貫戸 明子; 高矢 寿光; 小谷 泰史; 島岡 昌生; 飛梅 孝子; 中井 英勝; 辻 勲; 鈴木 彩子; 万代 昌紀  産婦人科手術  (27)  149  -149  2016/06
• 高齢者に対するweekly Paclitaxel+Carboplatin療法の後方視的検討

  飛梅 孝子; 中井 英勝; 宮川 知保; 藤島 理沙; 青木 稚人; 葉 宜慧; 村上 幸祐; 貫戸 明子; 高矢 寿光; 浮田 真沙世; 小谷 泰史; 島岡 昌生; 辻 勲; 鈴木 彩子; 万代 昌紀  日本婦人科腫瘍学会雑誌  34-  (3)  422  -422  2016/06
• 当科における腹腔鏡下子宮悪性腫瘍手術 教室員全員を術者として育成する

  小谷 泰史; 中井 英勝; 宮川 知保; 藤島 理沙; 青木 稚人; 葉 宜慧; 村上 幸祐; 貫戸 明子; 高矢 寿光; 浮田 真沙世; 島岡 昌生; 飛梅 孝子; 鈴木 彩子; 辻 勲; 万代 昌紀  日本婦人科腫瘍学会雑誌  34-  (3)  430  -430  2016/06
• 卵巣癌におけるベバシズマブ投与中・投与後の増悪に関する検討

  高矢 寿光; 中井 英勝; 村上 幸祐; 浮田 真沙世; 小谷 泰史; 飛梅 孝子; 鈴木 彩子; 辻 勲; 万代 昌紀  日本婦人科腫瘍学会雑誌  34-  (3)  442  -442  2016/06
• 婦人科癌患者の積極的治療とQOL維持のために産婦人科医ができること

  飛梅 孝子; 辻 勲; 鈴木 彩子; 中井 英勝; 島岡 昌生; 小谷 泰史; 高矢 寿光; 村上 幸祐; 葉 宜慧; 青木 稚人; 貫戸 明子; 万代 昌紀  日本産科婦人科学会雑誌  68-  (2)  678  -678  2016/02
• 腹腔鏡下子宮筋腫核出術における術後再発、再手術に関する検討

  小谷 泰史; 飛梅 孝子; 中井 英勝; 島岡 昌生; 高矢 寿光; 村上 幸祐; 鈴木 彩子; 万代 昌紀  日本内視鏡外科学会雑誌  20-  (7)  OS214  -1  2015/12
• 卵巣 卵巣がん治療の個別化に向けて 進行卵巣癌の術前化学療法の至適投与サイクル数-Long NACかShort NACか?

  浮田 真沙世; 藤島 理沙; 宮川 知保; 青木 稚人; 村上 幸祐; 貫戸 明子; 高矢 寿光; 小谷 泰史; 島岡 昌生; 飛梅 孝子; 中井 英勝; 辻 勲; 鈴木 彩子; 万代 昌紀  日本癌治療学会誌  50-  (3)  180  -180  2015/09
• 進行卵巣癌の術前化学療法におけるweekly TC療法の有用性

  高矢 寿光; 中井 英勝; 藤島 理沙; 宮川 知保; 青木 稚人; 村上 幸祐; 貫戸 明子; 浮田 真沙世; 小谷 泰史; 島岡 昌生; 飛梅 孝子; 辻 勲; 鈴木 彩子; 万代 昌紀  日本癌治療学会誌  50-  (3)  680  -680  2015/09
• ベバシズマブの再発卵巣癌における特有の効果・重篤な副作用発現について

  中井 英勝; 村上 幸助; 高矢 寿光; 浮田 真沙世; 青木 稚人; 鈴木 彩子; 飛梅 孝子; 島岡 昌生; 辻 勲; 貫戸 明子; 藤島 理沙; 宮川 知保; 小谷 泰史; 万代 昌紀  日本癌治療学会誌  50-  (3)  922  -922  2015/09
• 子宮 子宮体がん治療の個別化を目指して 進行・再発子宮体癌に対する経口シクロホスファミドの有用性

  村上 幸祐; 中井 英勝; 藤島 理沙; 宮川 知保; 青木 稚人; 貫戸 明子; 高矢 寿光; 浮田 真沙世; 小谷 泰史; 島岡 昌生; 飛梅 孝子; 辻 勲; 鈴木 彩子; 万代 昌紀  日本癌治療学会誌  50-  (3)  1091  -1091  2015/09
• 子宮 子宮体がん治療の新たな工夫 子宮筋腫と肉腫の鑑別に有用なMRI画像所見の設定とその解析

  鈴木 彩子; 青木 稚人; 藤島 理沙; 宮川 知保; 村上 幸祐; 高矢 寿光; 浮田 真沙世; 小谷 泰史; 島岡 昌生; 飛梅 孝子; 中井 英勝; 辻 勲; 万代 昌紀  日本癌治療学会誌  50-  (3)  1131  -1131  2015/09
• 腹腔鏡トレーニングボックスを用いた医学教育実習の導入と経験

  小谷 泰史; 鈴木 彩子; 辻 勲; 飛梅 孝子; 中井 英勝; 島岡 昌生; 浮田 真沙世; 高矢 寿光; 村上 幸祐; 青木 稚人; 万代 昌紀  医学教育  46-  (Suppl.)  184  -184  2015/07
• 当科におけるクリニカル・クラークシップへの講義型実習の導入の意義

  鈴木 彩子; 小谷 泰史; 青木 稚人; 村上 幸祐; 高矢 寿光; 浮田 真沙世; 島岡 昌生; 飛梅 孝子; 中井 英勝; 辻 勲; 万代 昌紀  医学教育  46-  (Suppl.)  205  -205  2015/07
• 初期子宮体癌に対する腹腔鏡下手術の導入

  高矢 寿光; 小谷 泰史; 青木 雅人; 村上 幸祐; 浮田 真沙世; 島岡 昌生; 中井 英勝; 飛梅 孝子; 小池 英爾; 辻 勲; 鈴木 彩子; 万代 昌紀  産婦人科手術  (26)  174  -174  2015/06
• 当科におけるロボット支援手術の導入における工夫

  小谷 泰史; 鈴木 彩子; 辻 勲; 飛梅 孝子; 中井 英勝; 小池 英爾; 島岡 昌生; 浮田 真沙世; 高矢 寿光; 村上 幸祐; 青木 雅人; 万代 昌紀  産婦人科手術  (26)  181  -181  2015/06
• MRI画像を用いた子宮筋腫と肉腫の鑑別診断に関する検討

  鈴木 彩子; 青木 稚人; 小谷 泰史; 辻 勲; 村上 幸祐; 高矢 寿光; 浮田 真沙世; 小池 英爾; 飛梅 孝子; 中井 英勝; 万代 昌紀  産婦人科手術  (26)  182  -182  2015/06
• 腹腔鏡手術における新たなセプラフィルム貼付法の検討

  青木 稚人; 小谷 泰史; 辻 勲; 飛梅 孝子; 中井 英勝; 小池 英爾; 島岡 昌生; 浮田 真沙世; 高矢 寿光; 村上 幸祐; 鈴木 彩子; 万代 昌紀  産婦人科手術  (26)  200  -200  2015/06
• 手術療法の新展開 当科におけるロボット支援下広汎子宮全摘術の現状 同時期に行った開腹広汎子宮全摘術と比較検討

  小谷 泰史; 鈴木 彩子; 辻 勲; 飛梅 孝子; 中井 英勝; 島岡 昌生; 浮田 真沙世; 高矢 寿光; 村上 幸祐; 青木 稚人; 万代 昌紀  日本婦人科腫瘍学会雑誌  33-  (3)  540  -540  2015/06
• 卵巣癌の術前化学療法におけるweekly TC療法の有用性

  高矢 寿光; 中井 英勝; 村上 幸祐; 浮田 真沙世; 小谷 泰史; 飛梅 孝子; 辻 勲; 鈴木 彩子; 万代 昌紀  日本婦人科腫瘍学会雑誌  33-  (3)  567  -567  2015/06
• 初期子宮体癌に対する腹腔鏡下手術における術前診断と術後病理診断の比較

  村上 幸祐; 青木 稚人; 高矢 寿光; 浮田 真沙世; 小谷 泰史; 島岡 昌生; 飛梅 孝子; 中井 英勝; 辻 勲; 鈴木 彩子; 万代 昌紀  日本婦人科腫瘍学会雑誌  33-  (3)  599  -599  2015/06
• 進行卵巣癌における術前化学療法の至適投与サイクル数についての検討

  浮田 真沙世; 青木 稚人; 村上 幸祐; 高矢 寿光; 小谷 泰史; 島岡 昌生; 飛梅 孝子; 中井 英勝; 辻 勲; 鈴木 彩子; 万代 昌紀  日本婦人科腫瘍学会雑誌  33-  (3)  605  -605  2015/06
• 婦人科癌患者の終末期医療の現状と課題

  飛梅 孝子; 中井 英勝; 高矢 寿光; 浮田 真沙世; 鈴木 彩子; 辻 勲; 村上 幸祐; 小谷 泰史; 万代 昌紀  日本婦人科腫瘍学会雑誌  33-  (3)  627  -627  2015/06
• 大量の腹腔内出血を呈した子宮漿膜内膜症の1例

  青木 稚人; 飛梅 孝子; 浮田 真沙世; 中井 英勝; 村上 幸祐; 高矢 寿光; 小谷 泰史; 島岡 昌生; 辻 勲; 鈴木 彩子; 万代 昌紀  産婦人科の進歩  67-  (2)  198  -198  2015/05
• 末期癌患者に対する腹水貯留例のCARTの有効性

  飛梅 孝子; 小谷 泰史; 辻 勲; 鈴木 彩子; 中井 英勝; 島岡 昌生; 浮田 真沙世; 高矢 寿光; 村上 幸祐; 貫戸 明子; 青木 稚人; 万代 昌紀  日本産科婦人科学会雑誌  67-  (2)  581  -581  2015/02
• 前置胎盤症例に対する分娩後バルーンとparallel vertical compression suturesの比較検討

  青木 稚人; 島岡 昌生; 村上 幸祐; 高矢 寿光; 浮田 真沙世; 小谷 泰史; 飛梅 孝子; 中井 英勝; 鈴木 彩子; 辻 勲; 万代 昌紀  日本産科婦人科学会雑誌  67-  (2)  796  -796  2015/02
• 子宮頸癌に対する術前化学療法についての検討

  高矢 寿光; 中井 英勝; 青木 稚人; 村上 幸祐; 浮田 真沙世; 小谷 泰史; 島岡 昌生; 飛梅 孝子; 辻 勲; 鈴木 彩子; 万代 昌紀  日本産科婦人科学会雑誌  67-  (2)  828  -828  2015/02
• 進行・再発子宮体癌に対する経口シクロホスファミドの有用性

  村上 幸祐; 中井 英勝; 青木 稚人; 高矢 寿光; 浮田 真沙世; 小谷 泰史; 島岡 昌生; 飛梅 孝子; 鈴木 彩子; 辻 勲; 万代 昌紀  日本産科婦人科学会雑誌  67-  (2)  837  -837  2015/02
• 卵巣癌術後化学療法におけるGnRHアナログの卵巣機能保護についての検討

  高矢 寿光; 中井 英勝; 青木 稚人; 村上 幸祐; 浮田 真沙世; 小谷 泰史; 島岡 昌生; 飛梅 孝子; 辻 勲; 鈴木 彩子; 万代 昌紀  産婦人科の進歩  66-  (4)  480  -480  2014/10
• 腹腔鏡下子宮筋腫核出術 手術成績からみた適応とその限界 腹腔鏡下子宮筋腫核出術における手術成績からみた適応と限界

  小谷 泰史; 飛梅 孝子; 中井 英勝; 小池 英爾; 島岡 昌生; 高矢 寿光; 村上 幸祐; 万代 昌紀  日本内視鏡外科学会雑誌  19-  (7)  346  -346  2014/10
• 当院における初期子宮体癌に対する腹腔鏡下子宮体がん根治手術の導入

  高矢 寿光; 小谷 泰史; 村上 幸祐; 島岡 昌生; 小池 英爾; 飛梅 孝子; 中井 英勝; 万代 昌紀  日本内視鏡外科学会雑誌  19-  (7)  641  -641  2014/10
• 腹腔鏡下子宮筋腫核出術における術後再発に関する検討

  村上 幸祐; 小谷 泰史; 高矢 寿光; 島岡 昌生; 小池 英爾; 飛梅 孝子; 中井 英勝; 万代 昌紀  日本内視鏡外科学会雑誌  19-  (7)  642  -642  2014/10
• 子宮内膜症手術における再発の検討

  飛梅 孝子; 小谷 泰史; 中井 英勝; 高矢 寿光; 村上 幸祐; 万代 昌紀  日本内視鏡外科学会雑誌  19-  (7)  808  -808  2014/10
• 【6科24術式 術式別でわかりやすい!内視鏡外科手術実践マニュアル】(第2章)レベルアップを目指すオペナースのための術式別マニュアル 産婦人科 腹腔鏡下子宮全摘術

  小谷 泰史; 万代 昌紀  オペナーシング  (2014秋季増刊)  206  -213  2014/09
• 子宮筋腫と肉腫の鑑別に有用なMRI画像所見に関する検討

  鈴木 彩子; 青木 稚人; 小谷 泰史; 辻 勲; 村上 幸祐; 高矢 寿光; 浮田 真沙世; 小池 英爾; 飛梅 孝子; 中井 英勝; 万代 昌紀  日本産科婦人科内視鏡学会雑誌  30-  (Suppl.I)  134  -134  2014/08
• 腹腔鏡手術における新たなセプラフィルム挿入、貼付における工夫

  青木 稚人; 小谷 泰史; 辻 勲; 飛梅 孝子; 中井 英勝; 小池 英爾; 島岡 昌生; 浮田 真沙世; 高矢 寿光; 村上 幸祐; 鈴木 彩子; 万代 昌紀  日本産科婦人科内視鏡学会雑誌  30-  (Suppl.I)  194  -194  2014/08
• 婦人科腹腔鏡手術後の術後QOLに対する研究

  小谷 泰史; 辻 勲; 飛梅 孝子; 中井 英勝; 小池 英爾; 島岡 昌生; 浮田 真沙世; 高矢 寿光; 村上 幸祐; 青木 稚人; 鈴木 彩子; 小畑 幸四郎; 万代 昌紀  日本産科婦人科内視鏡学会雑誌  30-  (Suppl.I)  217  -217  2014/08
• 卵巣チョコレートのう胞の術後再発率に関する検討

  浮田 真沙世; 飛梅 孝子; 小谷 泰史; 辻 勲; 中井 英勝; 小池 英爾; 島岡 昌生; 高矢 寿光; 村上 幸祐; 青木 稚人; 鈴木 彩子; 万代 昌紀  日本産科婦人科内視鏡学会雑誌  30-  (Suppl.I)  221  -221  2014/08
• 初期子宮体癌に対する腹腔鏡下手術の導入と成績

  高矢 寿光; 小谷 泰史; 青木 雅人; 村上 幸祐; 浮田 真沙世; 島岡 昌生; 中井 英勝; 飛梅 孝子; 小池 英爾; 辻 勲; 鈴木 彩子; 万代 昌紀  日本産科婦人科内視鏡学会雑誌  30-  (Suppl.I)  256  -256  2014/08
• 子宮内膜症性嚢胞手術症例における再発条件の検討

  飛梅 孝子; 小谷 泰史; 高矢 寿光; 万代 昌紀  日本エンドメトリオーシス学会会誌  35-  254  -256  2014/07
• 腹腔鏡下付属器腫瘍手術を行い術後に境界悪性及び悪性腫瘍と判明した症例についての検討

  小谷 泰史; 飛梅 孝子; 中井 英勝; 小池 英爾; 浮田 真沙世; 鈴木 彩子; 万代 昌紀  日本婦人科腫瘍学会雑誌  32-  (3)  504  -504  2014/06
• 子宮頸癌との鑑別に苦慮した子宮頸部非結核性抗酸菌症の1例

  浮田 真沙世; 小谷 泰史; 小池 英爾; 飛梅 孝子; 中井 英勝; 辻 勲; 鈴木 彩子; 万代 昌紀  日本婦人科腫瘍学会雑誌  32-  (3)  554  -554  2014/06
• 高齢の筋腫合併不妊症例に対する筋腫核出術の是非に関する検討

  辻 勲; 小谷 泰史; 貫戸 明子; 小池 英爾; 飛梅 孝子; 中井 英勝; 万代 昌紀  日本産科婦人科学会雑誌  66-  (2)  475  -475  2014/02
• 子宮頸癌術後の腟上皮内新生物に対する腟断端部焼灼術の後方視的検討

  中井 英勝; 飛梅 孝子; 小池 英爾; 小谷 泰史; 貫戸 明子; 辻 勲; 万代 昌紀  日本産科婦人科学会雑誌  66-  (2)  737  -737  2014/02
• 腹腔鏡下子宮筋腫核出術における術後再発率に関する検討

  小谷 泰史; 梅本 雅彦; 飛梅 孝子; 塩田 充  産婦人科の実際  62-  (3)  425  -429  2013/03
• 【産婦人科の薬剤使用プラクティス:病態別処方-婦人科編】腫瘍 子宮筋腫

  塩田 充; 梅本 雅彦; 飛梅 孝子; 小池 英爾; 小谷 泰史  産婦人科の実際  61-  (11)  1789  -1792  2012/10
• 【婦人科がん-最新の研究動向-】子宮体がん 子宮体癌の治療 外科治療 腹腔鏡下手術

  塩田 充; 梅本 雅彦; 飛梅 孝子; 小谷 泰史; 星合 昊  日本臨床  70-  (増刊4 婦人科がん)  400  -402  2012/06
• 子宮体がん 子宮体癌の進行期分類と治療方針

  塩田 充; 梅本雅彦; 飛梅孝子; 小谷泰史; 星合 昊  産婦人科の実際  61-  353  -357  2012/03
• 【これだけは知っておきたい手術の知識-最新情報からみた最近の話題-】産婦人科領域における腹腔鏡手術の現況と将来

  塩田 充; 梅本 雅彦; 飛梅 孝子; 小谷 泰史; 宇賀神 奈月; 星合 昊  産婦人科治療  103-  (6)  569  -575  2011/12
• 婦人科領域における単孔式腹腔鏡手術の現状と将来展望

  梅本雅彦; 飛梅孝子; 小谷泰史; 塩田 充; 星合 昊  産婦人科の進歩  63-  510  -513  2011/11
• 婦人科良性腫瘍の診断と治療

  梅本雅彦; 飛梅孝子; 小谷泰史; 塩田 充; 星合 昊  産婦人科の進歩  63-  158  -164  2011/05
• 子宮筋腫合併不妊症例に対する腹腔鏡手術の意義について

  辻 勲; 網 和美; 宮崎 綾子; 藤浪 菜穂子; 小谷 泰史; 飛梅 孝子; 梅本 雅彦; 塩田 充; 星合 昊  産婦人科の実際  59-  (10)  1563  -1568  2010/10
• 【内視鏡・内視鏡外科治療最前線 低侵襲治療の進歩】内視鏡外科治療の進歩 婦人科領域における腹腔鏡手術

  塩田 充; 梅本 雅彦; 飛梅 孝子; 小谷 泰史; 星合 昊  日本臨床  68-  (7)  1376  -1382  2010/07
• Nugent scoreを用いた細菌性腟症(BV)の診断と早産との関連に関する検討

  島岡 昌生; 釣谷 充弘; 小谷 泰史; 飛梅 孝子; 梅本 雅彦; 塩田 充; 星合 昊  日本産婦人科感染症研究会学術講演会記録集  28-  (28)  71  -80  2010/06
• 術前画像診断に基づいた卵巣腫瘍の術中被膜破綻率の推定

  梅本 雅彦; 飛梅 孝子; 島岡 昌生; 小谷 泰史; 塩田 充; 星合 昊  産婦人科の実際  59-  (6)  981  -985  2010/06
• 【より安全で女性にやさしい手術を目指して とくに妊孕能温存手術と腹腔鏡手術について】婦人科領域における内視鏡手術の現況と将来

  塩田 充; 梅本 雅彦; 飛梅 孝子; 小谷 泰史; 奥村 嘉英; 星合 昊  産婦人科治療  100-  (3)  271  -276  2010/03
• 婦人科領域における内視鏡手術の現状と将来

  塩田 充; 梅本雅彦; 飛梅孝子; 小谷泰史; 奥村嘉英; 星合 昊  産婦人科の治療  100-  271  -276  2010/03
• 【いま周産期領域に増えるリスク】増加する子宮筋腫合併妊娠 子宮筋腫、子宮腺筋症と妊娠

  小谷 泰史; 梅本 雅彦; 辻 勲; 飛梅 孝子; 島岡 昌生; 網 和美; 塩田 充; 星合 昊  産婦人科の実際  58-  (12)  1989  -1992  2009/11
• 【子宮筋腫の管理】子宮筋腫の治療

  塩田 充; 梅本 雅彦; 飛梅 孝子; 島岡 昌生; 小谷 泰史; 星合 昊  産婦人科治療  99-  (1)  37  -42  2009/07
• 原発不明癌に対する診断的腹腔鏡の適応経験

  江藤 智麿; 渡部 洋; 中井 英勝; 上田 晴彦; 小池 英爾; 小谷 泰史; 星合 昊  日本婦人科腫瘍学会雑誌  27-  (3)  320  -320  2009/06
• 当科における周術期抗凝固療法と副作用についての検討

  椎名 昌美; 保田 知生; 網 和美; 上田 晴彦; 小池 英爾; 小谷 泰史; 谷口 貢; 平野 豊; 宮崎 俊一; 星合 昊  Therapeutic Research  30-  (5)  733  -735  2009/05
• 【産婦人科手術療法マニュアル】婦人科手術 良性 腹式子宮筋腫核出術

  小谷 泰史; 梅本 雅彦; 飛梅 孝子; 島岡 昌生; 塩田 充; 星合 昊  産科と婦人科  76-  (Suppl.)  169  -174  2009/04
• 【内視鏡手術の適応と要約 治療におけるPros and Cons】腹腔鏡による子宮全摘

  塩田 充; 梅本 雅彦; 奥村 嘉英; 飛梅 孝子; 島岡 昌生; 小谷 泰史; 星合 昊  産婦人科の実際  56-  (1)  35  -39  2007/01
• 子宮筋腫・子宮腺筋症に対する腹腔鏡下腟式子宮全摘術

  塩田 充; 梅本雅彦; 飛梅孝子; 島岡昌生; 小谷泰史; 星合 昊  産婦人科の進歩  58-  164  -166  2006/05
• 【産婦人科診療におけるインフォームド・コンセント】不妊・生殖医療のインフォームド・コンセント 腹腔鏡による検査・治療

  塩田 充; 梅本 雅彦; 飛梅 孝子; 島岡 昌生; 小谷 泰史; 星合 昊  産婦人科の実際  54-  (11)  1869  -1877  2005/10
• 【ここまできた産婦人科腹腔鏡下手術】腹腔鏡下腟式子宮全摘術(LAVH)

  塩田 充; 梅本 雅彦; 飛梅 孝子; 島岡 昌生; 小谷 泰史; 高橋 陽子; 奥村 嘉英; 星合 昊  産婦人科治療  91-  (3)  265  -268  2005/09  [Invited]
  
• 【内視鏡手術時の合併症軽減のために】腹腔鏡 腹腔鏡下卵巣嚢腫摘出術・付属器摘出術

  梅本 雅彦; 塩田 充; 飛梅 孝子; 島岡 昌生; 小谷 泰史; 星合 昊  産婦人科の実際  54-  (1)  23  -28  2005/01
• 卵巣子宮内膜症の治療ストラテジー 卵巣子宮内膜症の癌化からみた卵巣子宮内膜症の治療ストラテジー

  小畑 孝四郎; 小池 英爾; 椎名 昌美; 島岡 昌生; 小谷 泰史; 梅本 雅彦; 塩田 充; 野田 起一郎; 星合 昊  エンドメトリオージス研究会会誌  25-  19  -26  2004/07

Awards & Honors

• 2022/02 近畿産婦人科内視鏡手術研究会 伊藤賞 審査員特別賞
  
• 2022 近畿大学医学会賞
  
• 2020/12 日本産科婦人科内視鏡学会 学会賞 (動画部門)
  
• 2010 近畿大学医学会賞
  
• 2009 近畿大学医学会賞
  

Research Grants & Projects

• 婦人科領域の腹腔鏡手術における術後QOLに関する研究

  公益財団法人 赤枝医学研究財団：助成研究

  Date (from‐to) : 2012/04 -2013/03 

  Author : 小谷泰史; 塩田 充; 梅本雅彦; 飛梅孝子

Others

• 2022/08  日本骨粗鬆症学会認定医
• 2022/06  日本婦人科ロボット手術学会 ロボット手術 プロクター
• 2021/12  性教育認定講師
• 2020/10  日本女性医学学会 女性ヘルスケア専門医・指導医
• 日本周産期・新生児医学会 母体・胎児専門医
• 日本ロボット外科学会専門医（国内B）
• 日本内視鏡外科学会技術認定医
• 日本産科婦人科内視鏡学会 内視鏡技術認定医（腹腔鏡・子宮鏡）
• 日本婦人科腫瘍学会婦人科腫瘍専門医・指導医
• 日本産科婦人科学会専門医・指導医

Other link

researchmap

https://researchmap.jp/kotani824